AB 2400: Prescription drug coverage: prior authorization and external review.
- Session Year: 2015-2016
- House: Assembly
- Latest Version Date: 2016-04-06
Existing federal law requires a group health plan and a health insurance issuer offering group or individual health insurance coverage to provide for a coverage appeals process, which includes both an internal review and an external review process, that applies if an enrollee receives an adverse benefit determination for a drug that is included on the health plans formulary drug list.
For plan years commencing on or after January 1, 2016, existing federal law requires a health plan providing essential health benefits to have procedures in place that allow an enrollee, the enrollees designee, or the enrollees prescribing provider to request and gain access to clinically appropriate nonformulary drugs within certain timeframes, and have an external review if the initial request is denied by the plan.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires health care service plans to establish and maintain a grievance system approved by the department under which enrollees may submit grievances to the plan and requires plans to resolve those grievances within 30 days, except as specified. Existing law requires individual, small group, and large group health care service plans and health insurers that provide prescription drug coverage to comply with the external exception request review process required by federal law for nonformulary drugs.
The bill would specify that for nonformulary drugs, an external exception request may be filed in lieu of filing a grievance with the health care service plan or health insurer following an adverse benefit determination. With respect to formulary drugs, the bill would require the grievance system established by the plan or an insurers internal grievance process to require a plan or insurer that provides coverage for outpatient prescription drugs to resolve grievances or complaints that involve the disapproval of a request for a formulary drug within 72 hours for nonurgent requests, and within 24 hours if exigent circumstances exist.
The bill would make other conforming changes to implement these changes.
Because a willful violation of these requirements by a health care service plan would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing federal law requires a group health plan and a health insurance issuer offering group or individual health insurance coverage to provide for a coverage appeals process, which includes both an internal review and an external review process, that applies if an enrollee receives an adverse benefit determination for a drug that is included on the health plans formulary drug list.
For plan years commencing on or after January 1, 2016, existing federal law requires a health plan providing essential health benefits to have procedures in place that allow an enrollee, the enrollees designee, or the enrollees prescribing provider to request and gain access to clinically appropriate nonformulary drugs within certain timeframes, and have an external review if the initial request is denied by the plan.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires health care service plans to establish and maintain a grievance system approved by the department under which enrollees may submit grievances to the plan and requires plans to resolve those grievances within 30 days, except as specified. Existing law requires individual, small group, and large group health care service plans and health insurers that provide prescription drug coverage to comply with the external exception request review process required by federal law for nonformulary drugs.
This bill would require those plans and insurers to also comply with that external exception request process for formulary drugs that require prior authorization by the plan or health insurer. The bill would specify that, for both nonformulary and formulary drugs, the external exception process is in lieu of the health care service plans grievance process and the health insurers internal review process following an adverse benefit determination.
The bill would specify that for nonformulary drugs, an external exception request may be filed in lieu of filing a grievance with the health care service plan or health insurer following an adverse benefit determination. With respect to formulary drugs, the bill would require the grievance system established by the plan or an insurers internal grievance process to require a plan or insurer that provides coverage for outpatient prescription drugs to resolve grievances or complaints that involve the disapproval of a request for a formulary drug within 72 hours for nonurgent requests, and within 24 hours if exigent circumstances exist.
The bill would make other conforming changes to implement these changes.
Because a willful violation of these requirements by a health care service plan would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing federal law requires a group health plan and a health insurance issuer offering group or individual health insurance coverage to provide for a coverage appeals process, which includes both an internal review and an external review process, that applies if an enrollee receives an adverse benefit determination for a drug that is included on the health plans formulary drug list.
For plan years commencing on or after January 1, 2016, existing federal law requires a health plan providing essential health benefits to have procedures in place that allow an enrollee, the enrollees designee, or the enrollees prescribing provider to request and gain access to clinically appropriate nonformulary drugs within certain timeframes, and have an external review if the initial request is denied by the plan.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires health care service plans to establish and maintain a grievance system approved by the department under which enrollees may submit grievances to the plan and requires plans to resolve those grievances within 30 days, except as specified. Existing law requires individual, small group, and large group health care service plans and health insurers that provide prescription drug coverage to comply with the external exception request process required by federal law for nonformulary drugs.
This bill would require those plans and insurers to also comply with that external exception request process for formulary drugs that require prior authorization by the plan or health insurer. The bill would specify that, for both nonformulary and formulary drugs, the external exception process is in lieu of the health care service plans grievance process and the health insurers internal review process following an adverse benefit determination.
The bill would make other conforming changes to implement these changes.
Because a willful violation of these requirements by a health care service plan would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(a)Every health care service plan that provides prescription drug benefits shall maintain an expeditious process by which prescribing providers may obtain authorization for a medically necessary nonformulary prescription drug. On or before July 1, 1999, every health care service plan that provides prescription drug benefits shall file with the department a description of its process, including timelines, for responding to authorization requests for nonformulary drugs. Any changes to this process shall be filed with the department pursuant to Section 1352. Each plan shall provide a written description of its most current process, including timelines, to its prescribing providers. For purposes of this section, a prescribing provider shall include a provider authorized to write a prescription, pursuant to subdivision (a) of Section 4040 of the Business and Professions Code, to treat a medical condition of an enrollee.
(b)Any plan that disapproves a request made pursuant to subdivision (a) by a prescribing provider to obtain authorization for a nonformulary drug shall provide the reasons for the disapproval in a notice provided to the enrollee. The notice shall indicate that the enrollee may file a grievance with the plan if the enrollee objects to the disapproval, including any alternative drug or treatment offered by the plan. The notice shall comply with subdivision (b) of Section 1368.02. Any health plan that is required to maintain an external exception request review process pursuant to subdivision (k) shall indicate in the notice required under this subdivision that the enrollee may file, in lieu of filing a grievance with the plan pursuant to Section 1368, a grievance seeking an external exception request review. An enrollee shall not be required to file a grievance with the plan or its contracting provider pursuant to Section 1368 if a plan disapproves a request to obtain authorization for a nonformulary drug under subdivision (a). If a plan disapproves a request to obtain authorization for a nonformulary drug and the enrollee files a grievance with the plan pursuant to Section 1368, the plan shall treat that request as a request to obtain an external exception request review.
(c)The process described in subdivision (a) by which prescribing providers may obtain authorization for medically necessary nonformulary drugs shall not apply to a nonformulary drug that has been prescribed for an enrollee in conformance with the provisions of Section 1367.22.
(d)The process described in subdivision (a) by which enrollees may obtain medically necessary nonformulary drugs, including specified timelines for responding to prescribing provider authorization requests, shall be described in evidence of coverage and disclosure forms, as required by subdivision (a) of Section 1363, issued on or after July 1, 1999.
(e)Every health care service plan that provides prescription drug benefits shall maintain, as part of its books and records under Section 1381, all of the following information, which shall be made available to the director upon request:
(1)The complete drug formulary or formularies of the plan, if the plan maintains a formulary, including a list of the prescription drugs on the formulary of the plan by major therapeutic category with an indication of whether any drugs are preferred over other drugs.
(2)Records developed by the pharmacy and therapeutic committee of the plan, or by others responsible for developing, modifying, and overseeing formularies, including medical groups, individual practice associations, and contracting pharmaceutical benefit management companies, used to guide the drugs prescribed for the enrollees of the plan, that fully describe the reasoning behind formulary decisions.
(3)Any plan arrangements with prescribing providers, medical groups, individual practice associations, pharmacists, contracting pharmaceutical benefit management companies, or other entities that are associated with activities of the plan to encourage formulary compliance or otherwise manage prescription drug benefits.
(f)If a plan provides prescription drug benefits, the department shall, as part of its periodic onsite medical survey of each plan undertaken pursuant to Section 1380, review the performance of the plan in providing those benefits, including, but not limited to, a review of the procedures and information maintained pursuant to this section, and describe the performance of the plan as part of its report issued pursuant to Section 1380.
(g)The director shall not publicly disclose any information reviewed pursuant to this section that is determined by the director to be confidential pursuant to state law.
(h)For purposes of this section, authorization means approval by the health care service plan to provide payment for the prescription drug.
(i)Nonformulary prescription drugs shall include any drug for which an enrollees copayment or out-of-pocket costs are different than the copayment for a formulary prescription drug, except as otherwise provided by law or regulation or in cases in which the drug has been excluded in the plan contract pursuant to Section 1342.7.
(j)Nothing in this section shall be construed to restrict or impair the application of any other provision of this chapter, including, but not limited to, Section 1367, which includes among its requirements that a health care service plan furnish services in a manner providing continuity of care and demonstrate that medical decisions are rendered by qualified medical providers unhindered by fiscal and administrative management.
(k)For any individual, small group, or large health plan contracts, a health care service plans process described in subdivision (a) shall comply with the request for exception and external exception request review processes described in subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations. This subdivision shall not apply to Medi-Cal managed care health care service plan contracts as described in subdivision (l).
(l)Medi-Cal managed care health care service plan contract means any entity that enters into a contract with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000), Chapter 8 (commencing with Section 14200), or Chapter 8.75 (commencing with Section 14591) of Part 3 of Division 9 of the Welfare and Institutions Code.
(m)Nothing in this section shall be construed to affect an enrollees or subscribers eligibility to submit a grievance to the department for review under Section 1368 or to apply to the department for an independent medical review under Section 1370.4, or Article 5.55 (commencing with Section 1374.30) of this chapter.
SEC. 2.Section 1368 of the Health and Safety Code is amended to read:1368.(a)Every plan shall do all of the following:
(1)Establish and maintain a grievance system approved by the department under which enrollees may submit their grievances to the plan. Each system shall provide reasonable procedures in accordance with department regulations that shall ensure adequate consideration of enrollee grievances and rectification when appropriate.
(2)Inform its subscribers and enrollees upon enrollment in the plan and annually thereafter of the procedure for processing and resolving grievances. The information shall include the location and telephone number where grievances may be submitted.
(3)Provide forms for grievances to be given to subscribers and enrollees who wish to register written grievances. The forms used by plans licensed pursuant to Section 1353 shall be approved by the director in advance as to format.
(4)(A)Provide for a written acknowledgment within five calendar days of the receipt of a grievance, except as noted in subparagraph (B). The acknowledgment shall advise the complainant of the following:
(i)That the grievance has been received.
(ii)The date of receipt.
(iii)The name of the plan representative and the telephone number and address of the plan representative who may be contacted about the grievance.
(B)(i)Grievances received by telephone, by facsimile, by email, or online through the plans Internet Web site pursuant to Section 1368.015, that are not coverage disputes, disputed health care services involving medical necessity, or experimental or investigational treatment and that are resolved by the next business day following receipt are exempt from the requirements of subparagraph (A) and paragraph (5). The plan shall maintain a log of all these grievances. The log shall be periodically reviewed by the plan and shall include the following information for each complaint:
(I)The date of the call.
(II)The name of the complainant.
(III)The complainants member identification number.
(IV)The nature of the grievance.
(V)The nature of the resolution.
(VI)The name of the plan representative who took the call and resolved the grievance.
(ii)For health plan contracts in the individual, small group, or large group markets, a health care service plans response to grievances subject to Section 1367.24 shall also comply with subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations. This paragraph shall not apply to Medi-Cal managed care health care service plan contracts or any entity that enters into a contract with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000), Chapter 8 (commencing with Section 14200), or Chapter 8.75 (commencing with Section 14591) of Part 3 of Division 9 of the Welfare and Institutions Code.
(5)Provide subscribers and enrollees with written responses to grievances, with a clear and concise explanation of the reasons for the plans response. For grievances involving the delay, denial, or modification of health care services, the plan response shall describe the criteria used and the clinical reasons for its decision, including all criteria and clinical reasons related to medical necessity. If a plan, or one of its contracting providers, issues a decision delaying, denying, or modifying health care services based in whole or in part on a finding that the proposed health care services are not a covered benefit under the contract that applies to the enrollee, the decision shall clearly specify the provisions in the contract that exclude that coverage.
(6)For grievances involving the cancellation, rescission, or nonrenewal of a health care service plan contract, the health care service plan shall continue to provide coverage to the enrollee or subscriber under the terms of the health care service plan contract until a final determination of the enrollees or subscribers request for review has been made by the health care service plan or the director pursuant to Section 1365 and this section. This paragraph shall not apply if the health care service plan cancels or fails to renew the enrollees or subscribers health care service plan contract for nonpayment of premiums pursuant to paragraph (1) of subdivision (a) of Section 1365.
(7)Keep in its files all copies of grievances, and the responses thereto, for a period of five years.
(b)(1)(A)After completing the grievance process described in subdivision (a), participating in the process for at least 30 days, or completing the external exception request review process described in subdivision (k) of Section 1367.24, a subscriber or enrollee may submit the grievance or external exception request review decision to the department for review. In any case under the grievance process determined by the department to be a case involving an imminent and serious threat to the health of the patient, including, but not limited to, severe pain, the potential loss of life, limb, or major bodily function, cancellations, rescissions, or the nonrenewal of a health care service plan contract, or in any other case when the department determines that an earlier review is warranted, a subscriber or enrollee shall not be required to complete the grievance process or to participate in the process for at least 30 days before submitting a grievance to the department for review.
(B)A grievance or external exception request review decision may be submitted to the department for review and resolution prior to any arbitration.
(C)Notwithstanding subparagraphs (A) and (B), the department may refer any grievance or external exception request review decision that does not pertain to compliance with this chapter to the State Department of Public Health, the California Department of Aging, the federal Centers for Medicare and Medicaid Services, or any other appropriate governmental entity for investigation and resolution.
(2)If the subscriber or enrollee is a minor, or is incompetent or incapacitated, the parent, guardian, conservator, relative, or other designee of the subscriber or enrollee, as appropriate, may submit the grievance or external exception request review decision to the department as the agent of the subscriber or enrollee. Further, a provider may join with, or otherwise assist, a subscriber or enrollee, or the agent, to submit the grievance or external exception request review decision to the department. In addition, following submission of the grievance or external exception request review decision to the department, the subscriber or enrollee, or the agent, may authorize the provider to assist, including advocating on behalf of the subscriber or enrollee. For purposes of this section, a relative includes the parent, stepparent, spouse, adult son or daughter, grandparent, brother, sister, uncle, or aunt of the subscriber or enrollee.
(3)The department shall review the written documents submitted with the subscribers or the enrollees request for review, or submitted by the agent on behalf of the subscriber or enrollee. The department may ask for additional information, and may hold an informal meeting with the involved parties, including providers who have joined in submitting the grievance or external exception request review decision or who are otherwise assisting or advocating on behalf of the subscriber or enrollee. If after reviewing the record, the department concludes that the grievance or external exception request review decision, in whole or in part, is eligible for review under the independent medical review system established pursuant to Article 5.55 (commencing with Section 1374.30), the department shall immediately notify the subscriber or enrollee, or agent, of that option and shall, if requested orally or in writing, assist the subscriber or enrollee in participating in the independent medical review system.
(4)If after reviewing the record of a grievance or external exception request review decision, the department concludes that a health care service eligible for coverage and payment under a health care service plan contract has been delayed, denied, or modified by a plan, or by one of its contracting providers, in whole or in part due to a determination that the service is not medically necessary, and that determination was not communicated to the enrollee in writing along with a notice of the enrollees potential right to participate in the independent medical review system, as required by this chapter, the director shall, by order, assess administrative penalties. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice of, and the opportunity for, a hearing with regard to the person affected in accordance with Section 1397. The administrative penalties shall not be deemed an exclusive remedy available to the director. These penalties shall be paid to the Managed Care Administrative Fines and Penalties Fund and shall be used for the purposes specified in Section 1341.45.
(5)The department shall send a written notice of the final disposition of the grievance or external exception request review decision, and the reasons therefor, to the subscriber or enrollee, the agent, to any provider that has joined with or is otherwise assisting the subscriber or enrollee, and to the plan, within 30 calendar days of receipt of the request for review unless the director, in his or her discretion, determines that additional time is reasonably necessary to fully and fairly evaluate the relevant grievance or external exception request review decision. In any case not eligible for the independent medical review system established pursuant to Article 5.55 (commencing with Section 1374.30), the departments written notice shall include, at a minimum, the following:
(A)A summary of its findings and the reasons why the department found the plan to be, or not to be, in compliance with any applicable laws, regulations, or orders of the director.
(B)A discussion of the departments contact with any medical provider, or any other independent expert relied on by the department, along with a summary of the views and qualifications of that provider or expert.
(C)If the enrollees grievance or external exception request review decision is sustained in whole or in part, information about any corrective action taken.
(6)In any department review of a grievance or external exception request review decision involving a disputed health care service, as defined in subdivision (b) of Section 1374.30, that is not eligible for the independent medical review system established pursuant to Article 5.55 (commencing with Section 1374.30), in which the department finds that the plan has delayed, denied, or modified health care services that are medically necessary, based on the specific medical circumstances of the enrollee, and those services are a covered benefit under the terms and conditions of the health care service plan contract, the departments written notice shall do either of the following:
(A)Order the plan to promptly offer and provide those health care services to the enrollee.
(B)Order the plan to promptly reimburse the enrollee for any reasonable costs associated with urgent care or emergency services, or other extraordinary and compelling health care services, when the department finds that the enrollees decision to secure those services outside of the plan network was reasonable under the circumstances.
The departments order shall be binding on the plan.
(7)Distribution of the written notice shall not be deemed a waiver of any exemption or privilege under existing law, including, but not limited to, Section 6254.5 of the Government Code, for any information in connection with and including the written notice, nor shall any person employed or in any way retained by the department be required to testify as to that information or notice.
(8)The director shall establish and maintain a system of aging of grievances that are pending and unresolved for 30 days or more that shall include a brief explanation of the reasons each grievance is pending and unresolved for 30 days or more.
(9)A subscriber or enrollee, or the agent acting on behalf of a subscriber or enrollee, may also request voluntary mediation with the plan prior to exercising the right to submit a grievance or external exception request review decision to the department. The use of mediation services shall not preclude the right to submit a grievance or external exception request review decision to the department upon completion of mediation. In order to initiate mediation, the subscriber or enrollee, or the agent acting on behalf of the subscriber or enrollee, and the plan shall voluntarily agree to mediation. Expenses for mediation shall be borne equally by both sides. The department shall have no administrative or enforcement responsibilities in connection with the voluntary mediation process authorized by this paragraph.
(c)The plans grievance system shall include a system of aging of grievances that are pending and unresolved for 30 days or more. The plan shall provide a quarterly report to the director of grievances pending and unresolved for 30 or more days with separate categories of grievances for Medicare enrollees and Medi-Cal enrollees. The plan shall include with the report a brief explanation of the reasons each grievance is pending and unresolved for 30 days or more. The plan may include the following statement in the quarterly report that is made available to the public by the director:
Under Medicare and Medi-Cal law, Medicare enrollees and Medi-Cal enrollees each have separate avenues of appeal that are not available to other enrollees. Therefore, grievances pending and unresolved may reflect enrollees pursuing their Medicare or Medi-Cal appeal rights.
If requested by a plan, the director shall include this statement in a written report made available to the public and prepared by the director that describes or compares grievances that are pending and unresolved with the plan for 30 days or more. Additionally, the director shall, if requested by a plan, append to that written report a brief explanation, provided in writing by the plan, of the reasons why grievances described in that written report are pending and unresolved for 30 days or more. The director shall not be required to include a statement or append a brief explanation to a written report that the director is required to prepare under this chapter, including Sections 1380 and 1397.5.
(d)Subject to subparagraph (C) of paragraph (1) of subdivision (b), the grievance or resolution procedures authorized by this section shall be in addition to any other procedures that may be available to any person, and failure to pursue, exhaust, or engage in the procedures described in this section shall not preclude the use of any other remedy provided by law.
(e)Nothing in this section shall be construed to allow the submission to the department of any provider grievance under this section. However, as part of a providers duty to advocate for medically appropriate health care for his or her patients pursuant to Sections 510 and 2056 of the Business and Professions Code, nothing in this subdivision shall be construed to prohibit a provider from contacting and informing the department about any concerns he or she has regarding compliance with or enforcement of this chapter.
(f)To the extent required by Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations, there shall be an independent external review pursuant to the standards required by the United States Secretary of Health and Human Services of a health care service plans cancellation, rescission, or nonrenewal of an enrollees or subscribers coverage.
SEC. 3.Section 1368.01 of the Health and Safety Code is amended to read:1368.01.(a)The grievance system shall require the plan to resolve grievances within 30 days, except as provided in subdivisions (c) and (d).
(b) The grievance system shall include a requirement for expedited plan review of grievances for cases involving an imminent and serious threat to the health of the patient, including, but not limited to, severe pain, potential loss of life, limb, or major bodily function. When the plan has notice of a case requiring expedited review, the grievance system shall require the plan to immediately inform enrollees and subscribers in writing of their right to notify the department of the grievance. The grievance system shall also require the plan to provide enrollees, subscribers, and the department with a written statement on the disposition or pending status of the grievance no later than three days from receipt of the grievance, except as provided in subdivision (c). Paragraph (4) of subdivision (a) of Section 1368 shall not apply to grievances handled pursuant to this section.
(c)A health care service plan contract in the individual, small group, or large group markets that provides coverage for outpatient prescription drugs shall comply with subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations. This subdivision shall not apply to Medi-Cal managed care health care service plan contracts or any entity that enters into a contract with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000), Chapter 8 (commencing with Section 14200), or Chapter 8.75 (commencing with Section 14591) of Part 3 of Division 9 of the Welfare and Institutions Code.
(d)The grievance system shall require a health care service plan that provides coverage for outpatient prescription drugs to resolve grievances within 72 hours for nonurgent requests, and within 24 hours if exigent circumstances exist, if the original request was an authorization for a formulary drug that requires prior authorization by the plan. For purposes of this subdivision, exigent circumstances shall have the same meaning as set forth in Section 1367.241.
SEC. 4.Section 1374.30 of the Health and Safety Code is amended to read:1374.30.(a)Commencing January 1, 2001, there is hereby established in the department the Independent Medical Review System.
(b)For the purposes of this chapter, disputed health care service means any health care service eligible for coverage and payment under a health care service plan contract that has been denied, modified, or delayed by a decision of the plan, or by one of its contracting providers, in whole or in part due to a finding that the service is not medically necessary. A decision regarding a disputed health care service relates to the practice of medicine and is not a coverage decision. A disputed health care service does not include services provided by a specialized health care service plan, except to the extent that the service (1) involves the practice of medicine, or (2) is provided pursuant to a contract with a health care service plan that covers hospital, medical, or surgical benefits. If a plan, or one of its contracting providers, issues a decision denying, modifying, or delaying health care services, based in whole or in part on a finding that the proposed health care services are not a covered benefit under the contract that applies to the enrollee, the statement of decision shall clearly specify the provision in the contract that excludes that coverage.
(c)For the purposes of this chapter, coverage decision means the approval or denial of health care services by a plan, or by one of its contracting entities, substantially based on a finding that the provision of a particular service is included or excluded as a covered benefit under the terms and conditions of the health care service plan contract. A coverage decision does not encompass a plan or contracting provider decision regarding a disputed health care service.
(d)(1)All enrollee grievances involving a disputed health care service are eligible for review under the Independent Medical Review System if the requirements of this article are met. If the department finds that an enrollee grievance involving a disputed health care service does not meet the requirements of this article for review under the Independent Medical Review System, the enrollee request for review shall be treated as a request for the department to review the grievance pursuant to subdivision (b) of Section 1368. All other enrollee grievances, including grievances involving coverage decisions, remain eligible for review by the department pursuant to subdivision (b) of Section 1368.
(2)In any case in which an enrollee or provider asserts that a decision to deny, modify, or delay health care services was based, in whole or in part, on consideration of medical necessity, the department shall have the final authority to determine whether the grievance is more properly resolved pursuant to an independent medical review as provided under this article or pursuant to subdivision (b) of Section 1368.
(3)The department shall be the final arbiter when there is a question as to whether an enrollee grievance is a disputed health care service or a coverage decision. The department shall establish a process to complete an initial screening of an enrollee grievance. If there appears to be any medical necessity issue, the grievance shall be resolved pursuant to an independent medical review as provided under this article or pursuant to subdivision (b) of Section 1368.
(e)Every health care service plan contract that is issued, amended, renewed, or delivered in this state on or after January 1, 2000, shall provide an enrollee with the opportunity to seek an independent medical review whenever health care services have been denied, modified, or delayed by the plan, or by one of its contracting providers, if the decision was based in whole or in part on a finding that the proposed health care services are not medically necessary. For purposes of this article, an enrollee may designate an agent to act on his or her behalf, as described in paragraph (2) of subdivision (b) of Section 1368. The provider may join with or otherwise assist the enrollee in seeking an independent medical review, and may advocate on behalf of the enrollee.
(f)Medi-Cal beneficiaries enrolled in a health care service plan shall not be excluded from participation. Medicare beneficiaries enrolled in a health care service plan shall not be excluded unless expressly preempted by federal law. Reviews of cases for Medi-Cal enrollees shall be conducted in accordance with statutes and regulations for the Medi-Cal program.
(g)The department may seek to integrate the quality of care and consumer protection provisions, including remedies, of the Independent Medical Review System with related dispute resolution procedures of other health care agency programs, including the Medicare and Medi-Cal programs, in a way that minimizes the potential for duplication, conflict, and added costs. Nothing in this subdivision shall be construed to limit any rights conferred upon enrollees under this chapter.
(h)The independent medical review process authorized by this article is in addition to any other procedures or remedies that may be available.
(i)Every health care service plan shall prominently display in every plan member handbook or relevant informational brochure, in every plan contract, on enrollee evidence of coverage forms, on copies of plan procedures for resolving grievances, on letters of denials issued by either the plan or its contracting organization, on the grievance forms required under Section 1368, and on all written responses to grievances, information concerning the right of an enrollee to request an independent medical review in cases where the enrollee believes that health care services have been improperly denied, modified, or delayed by the plan, or by one of its contracting providers.
(j)An enrollee may apply to the department for an independent medical review when all of the following conditions are met:
(1)(A)The enrollees provider has recommended a health care service as medically necessary. necessary, or
(B)The enrollee has received urgent care or emergency services that a provider determined was medically necessary. necessary, or
(C)The enrollee, in the absence of a provider recommendation under subparagraph (A) or the receipt of urgent care or emergency services by a provider under subparagraph (B), has been seen by an in-plan provider for the diagnosis or treatment of the medical condition for which the enrollee seeks independent review. The plan shall expedite access to an in-plan provider upon request of an enrollee. The in-plan provider need not recommend the disputed health care service as a condition for the enrollee to be eligible for an independent review.
For purposes of this article, the enrollees provider may be an out-of-plan provider. However, the plan shall have no liability for payment of services provided by an out-of-plan provider, except as provided pursuant to subdivision (c) of Section 1374.34.
(2)The disputed health care service has been denied, modified, or delayed by the plan, or by one of its contracting providers, based in whole or in part on a decision that the health care service is not medically necessary.
(3)Either of the following:
(A)The enrollee has filed a grievance with the plan or its contracting provider pursuant to Section 1368, and the disputed decision is upheld or the grievance remains unresolved after 30 days. The enrollee shall not be required to participate in the plans grievance process for more than 30 days. In the case of a grievance that requires expedited review pursuant to subdivision (b) of Section 1368.01, the enrollee shall not be required to participate in the plans grievance process for more than three days. In the case of a grievance that requires expedited review pursuant to subdivision (d) of Section 1368.01, the enrollee shall not be required to participate in the plans grievance process for more than 72 hours, or more than 24 hours if exigent circumstances exist.
(B)The enrollee has filed for an external exception request review decision with the plan or its contracting provider pursuant to subdivision (k) of Section 1367.24, and the disputed decision is upheld or the external review remains unresolved after 72 hours, or after 24 hours if exigent circumstances exist.
(k)An enrollee may apply to the department for an independent medical review of a decision to deny, modify, or delay health care services, based in whole or in part on a finding that the disputed health care services are not medically necessary, within six months of any of the qualifying periods or events under subdivision (j). The director may extend the application deadline beyond six months if the circumstances of a case warrant the extension.
(l)The enrollee shall pay no application or processing fees of any kind.
(m)As part of its notification to the enrollee regarding a disposition of the enrollees grievance that denies, modifies, or delays health care services, the plan shall provide the enrollee with a one- or two-page application form approved by the department, and an addressed envelope, which the enrollee may return to initiate an independent medical review. The plan shall include on the form any information required by the department to facilitate the completion of the independent medical review, such as the enrollees diagnosis or condition, the nature of the disputed health care service sought by the enrollee, a means to identify the enrollees case, and any other material information. The form shall also include the following:
(1)Notice that a decision not to participate in the independent medical review process may cause the enrollee to forfeit any statutory right to pursue legal action against the plan regarding the disputed health care service.
(2)A statement indicating the enrollees consent to obtain any necessary medical records from the plan, any of its contracting providers, and any out-of-plan provider the enrollee may have consulted on the matter, to be signed by the enrollee.
(3)Notice of the enrollees right to provide information or documentation, either directly or through the enrollees provider, regarding any of the following:
(A)A provider recommendation indicating that the disputed health care service is medically necessary for the enrollees medical condition.
(B)Medical information or justification that a disputed health care service, on an urgent care or emergency basis, was medically necessary for the enrollees medical condition.
(C)Reasonable information supporting the enrollees position that the disputed health care service is or was medically necessary for the enrollees medical condition, including all information provided to the enrollee by the plan or any of its contracting providers, still in the possession of the enrollee, concerning a plan or provider decision regarding disputed health care services, and a copy of any materials the enrollee submitted to the plan, still in the possession of the enrollee, in support of the grievance, as well as any additional material that the enrollee believes is relevant.
(4)A section designed to collect information on the enrollees ethnicity, race, and primary language spoken that includes both of the following:
(A)A statement of intent indicating that the information is used for statistics only, in order to ensure that all enrollees get the best care possible.
(B)A statement indicating that providing this information is optional and will not affect the independent medical review process in any way.
(n)Upon notice from the department that the health care service plans enrollee has applied for an independent medical review, the plan or its contracting providers shall provide to the independent medical review organization designated by the department a copy of all of the following documents within three business days of the plans receipt of the departments notice of a request by an enrollee for an independent review:
(1)(A)A copy of all of the enrollees medical records in the possession of the plan or its contracting providers relevant to each of the following:
(i)The enrollees medical condition.
(ii)The health care services being provided by the plan and its contracting providers for the condition.
(iii)The disputed health care services requested by the enrollee for the condition.
(B)Any newly developed or discovered relevant medical records in the possession of the plan or its contracting providers after the initial documents are provided to the independent medical review organization shall be forwarded immediately to the independent medical review organization. The plan shall concurrently provide a copy of medical records required by this subparagraph to the enrollee or the enrollees provider, if authorized by the enrollee, unless the offer of medical records is declined or otherwise prohibited by law. The confidentiality of all medical record information shall be maintained pursuant to applicable state and federal laws.
(2)A copy of all information provided to the enrollee by the plan and any of its contracting providers concerning plan and provider decisions regarding the enrollees condition and care, and a copy of any materials the enrollee or the enrollees provider submitted to the plan and to the plans contracting providers in support of the enrollees request for disputed health care services. This documentation shall include the written response to the enrollees grievance, required by paragraph (4) of subdivision (a) of Section 1368. The confidentiality of any enrollee medical information shall be maintained pursuant to applicable state and federal laws.
(3)A copy of any other relevant documents or information used by the plan or its contracting providers in determining whether disputed health care services should have been provided, and any statements by the plan and its contracting providers explaining the reasons for the decision to deny, modify, or delay disputed health care services on the basis of medical necessity. The plan shall concurrently provide a copy of documents required by this paragraph, except for any information found by the director to be legally privileged information, to the enrollee and the enrollees provider. The department and the independent medical review organization shall maintain the confidentiality of any information found by the director to be the proprietary information of the plan.
(o)This section shall become operative on July 1, 2015.
SEC. 5.Section 10123.191 of the Insurance Code is amended to read:10123.191.(a)Notwithstanding any other law, on and after January 1, 2013, a health insurer that provides coverage for prescription drugs shall utilize and accept only the prior authorization form developed pursuant to subdivision (c), or an electronic prior authorization process described in subdivision (e), when requiring prior authorization for prescription drugs.
(b)(1)If a health insurer or a contracted physician group fails to respond within 72 hours for nonurgent requests, and within 24 hours if exigent circumstances exist, upon receipt of a completed prior authorization request from a prescribing provider, the prior authorization request shall be deemed to have been granted.
(2)A health insurers internal grievance process shall require a health insurer that provides coverage for outpatient prescription drugs to resolve grievances within 72 hours for nonurgent requests, and within 24 hours if exigent circumstances exist, if the original request was an authorization for a formulary drug that requires prior authorization by the health insurer.
(c)On or before January 1, 2017, the department and the Department of Managed Health Care shall jointly develop a uniform prior authorization form. Notwithstanding any other law, on and after July 1, 2017, or six months after the form is completed pursuant to this section, whichever is later, every prescribing provider shall use that uniform prior authorization form, or an electronic prior authorization process described in subdivision (e), to request prior authorization for coverage of prescription drugs and every health insurer shall accept that form or electronic process as sufficient to request prior authorization for prescription drugs.
(d)The prior authorization form developed pursuant to subdivision (c) shall meet the following criteria:
(1)The form shall not exceed two pages.
(2)The form shall be made electronically available by the department and the health insurer.
(3)The completed form may also be electronically submitted from the prescribing provider to the health insurer.
(4)The department and the Department of Managed Health Care shall develop the form with input from interested parties from at least one public meeting.
(5)The department and the Department of Managed Health Care, in development of the standardized form, shall take into consideration the following:
(A)Existing prior authorization forms established by the federal Centers for Medicare and Medicaid Services and the State Department of Health Care Services.
(B)National standards pertaining to electronic prior authorization.
(e)A prescribing provider may use an electronic prior authorization system utilizing the standardized form described in subdivision (c) or an electronic process developed specifically for transmitting prior authorization information that meets the National Council for Prescription Drug Programs SCRIPT standard for electronic prior authorization transactions.
(f)Subdivision (a) does not apply if any of the following occurs:
(1)A contracted physician group is delegated the financial risk for the pharmacy or medical drug benefit by a health insurer.
(2)A contracted physician group uses its own internal prior authorization process rather than the health insurers prior authorization process for the health insurers insureds.
(3)A contracted physician group is delegated a utilization management function by the health insurer concerning any prescription drug, regardless of the delegation of financial risk.
(g)For prescription drugs, prior authorization requirements described in subdivisions (c) and (e) apply regardless of how that benefit is classified under the terms of the health insurers group or individual policy.
(h)(1)A health insurer shall maintain a process for an external exception request review that complies with subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations.
(2)An insured shall not be required to file a complaint with the health insurer or its contracting provider pursuant to its internal grievance process if a health insurer disapproves a request to obtain authorization for a nonformulary drug under subdivision (i). If a health insurer disapproves a request to obtain authorization for a nonformulary drug and the insured files a complaint with the health insurer, the health insurer shall treat that as a request to obtain an external exception request review.
(i)For an individual, small group, or large group health insurance policy, a health insurer that provides coverage for outpatient prescription drugs shall comply with subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations.
(j)Nothing in this section shall be construed to affect an insureds or policyholders eligibility to submit a complaint to the department for review or to apply to the department for an independent medical review under Article 3.5 (commencing with Section 10169).
(k)For purposes of this section:
(1)Prescribing provider shall include a provider authorized to write a prescription, pursuant to subdivision (a) of Section 4040 of the Business and Professions Code, to treat a medical condition of an insured.
(2)Exigent circumstances exist when an insured is suffering from a health condition that may seriously jeopardize the insureds life, health, or ability to regain maximum function or when an insured is undergoing a current course of treatment using a nonformulary drug.
(3)Completed prior authorization request means a completed uniform prior authorization form developed pursuant to subdivision (c), or a completed request submitted using an electronic prior authorization system described in subdivision (e), or, for contracted physician groups described in subdivision (f), the process used by the contracted physician group.
SEC. 6.Section 10169 of the Insurance Code, as added by Section 19 of Chapter 348 of the Statutes of 2015, is amended to read:10169.(a)Commencing January 1, 2001, there is hereby established in the department the Independent Medical Review System.
(b)For the purposes of this chapter, disputed health care service means any health care service eligible for coverage and payment under a disability insurance contract that has been denied, modified, or delayed by a decision of the insurer, or by one of its contracting providers, in whole or in part due to a finding that the service is not medically necessary. A decision regarding a disputed health care service relates to the practice of medicine and is not a coverage decision. A disputed health care service does not include services provided by a group or individual policy of vision-only or dental-only coverage, except to the extent that (1) the service involves the practice of medicine, or (2) is provided pursuant to a contract with a disability insurer that covers hospital, medical, or surgical benefits. If an insurer, or one of its contracting providers, issues a decision denying, modifying, or delaying health care services, based in whole or in part on a finding that the proposed health care services are not a covered benefit under the contract that applies to the insured, the statement of decision shall clearly specify the provision in the contract that excludes that coverage.
(c)For the purposes of this chapter, coverage decision means the approval or denial of health care services by a disability insurer, or by one of its contracting entities, substantially based on a finding that the provision of a particular service is included or excluded as a covered benefit under the terms and conditions of the disability insurance contract. A coverage decision does not encompass a disability insurer or contracting provider decision regarding a disputed health care service.
(d)(1)All insured grievances involving a disputed health care service are eligible for review under the Independent Medical Review System if the requirements of this article are met. If the department finds that an insured grievance involving a disputed health care service does not meet the requirements of this article for review under the Independent Medical Review System, the insured request for review shall be treated as a request for the department to review the grievance. All other insured grievances, including grievances involving coverage decisions, remain eligible for review by the department.
(2)In any case in which an insured or provider asserts that a decision to deny, modify, or delay health care services was based, in whole or in part, on consideration of medical necessity, the department shall have the final authority to determine whether the grievance is more properly resolved pursuant to an independent medical review as provided under this article.
(3)The department shall be the final arbiter when there is a question as to whether an insured grievance is a disputed health care service or a coverage decision. The department shall establish a process to complete an initial screening of an insured grievance. If there appears to be any medical necessity issue, the grievance shall be resolved pursuant to an independent medical review as provided under this article.
(e)Every disability insurance contract that is issued, amended, renewed, or delivered in this state on or after January 1, 2000, shall provide an insured with the opportunity to seek an independent medical review whenever health care services have been denied, modified, or delayed by the insurer, or by one of its contracting providers, if the decision was based in whole or in part on a finding that the proposed health care services are not medically necessary. For purposes of this article, an insured may designate an agent to act on his or her behalf. The provider may join with or otherwise assist the insured in seeking an independent medical review, and may advocate on behalf of the insured.
(f)Medicare beneficiaries enrolled in Medicare + Choice products shall not be excluded unless expressly preempted by federal law.
(g)The department may seek to integrate the quality of care and consumer protection provisions, including remedies, of the Independent Medical Review System with related dispute resolution procedures of other health care agency programs, including the Medicare program, in a way that minimizes the potential for duplication, conflict, and added costs. Nothing in this subdivision shall be construed to limit any rights conferred upon insureds under this chapter.
(h)The independent medical review process authorized by this article is in addition to any other procedures or remedies that may be available.
(i)Every disability insurer shall prominently display in every insurer member handbook or relevant informational brochure, in every insurance contract, on insured evidence of coverage forms, on copies of insurer procedures for resolving grievances, on letters of denials issued by either the insurer or its contracting organization, and on all written responses to grievances, information concerning the right of an insured to request an independent medical review when the insured believes that health care services have been improperly denied, modified, or delayed by the insurer, or by one of its contracting providers. The departments telephone number, 1-800-927-4357, and Internet Web site, www.insurance.ca.gov, shall also be displayed.
(j)An insured may apply to the department for an independent medical review when all of the following conditions are met:
(1)(A)The insureds provider has recommended a health care service as medically necessary, or
(B)The insured has received urgent care or emergency services that a provider determined was medically necessary, or
(C)The insured, in the absence of a provider recommendation under subparagraph (A) or the receipt of urgent care or emergency services by a provider under subparagraph (B), has been seen by a contracting provider for the diagnosis or treatment of the medical condition for which the insured seeks independent review. The insurer shall expedite access to a contracting provider upon request of an insured. The contracting provider need not recommend the disputed health care service as a condition for the insured to be eligible for an independent review.
For purposes of this article, the insureds provider may be a noncontracting provider. However, the insurer shall have no liability for payment of services provided by a noncontracting provider, except as provided pursuant to Section 10169.3.
(2)The disputed health care service has been denied, modified, or delayed by the insurer, or by one of its contracting providers, based in whole or in part on a decision that the health care service is not medically necessary.
(3)Either of the following:
(A)The insured has filed a grievance with the insurer or its contracting provider, and the disputed decision is upheld or the grievance remains unresolved after 30 days. The insured shall not be required to participate in the insurers grievance process for more than 30 days. In the case of a grievance that requires expedited review, the insured shall not be required to participate in the insurers grievance process for more than three days. In the case of a grievance that requires expedited review pursuant to paragraph (2) of subdivision (b) of Section 10123.191, the insured shall not be required to participate in the insureds grievance process for more than 72 hours, or more than 24 hours if exigent circumstances exist.
(B)The insured has filed for an external exception request review decision with the insurer or its contracting provider pursuant to subdivision (h) of Section 10123.191, and the disputed decision is upheld or the external review remains unresolved after 72 hours, or after 24 hours if exigent circumstances exist.
(k)An insured may apply to the department for an independent medical review of a decision to deny, modify, or delay health care services, based in whole or in part on a finding that the disputed health care services are not medically necessary, within six months of any of the qualifying periods or events under subdivision (j). The commissioner may extend the application deadline beyond six months if the circumstances of a case warrant the extension.
(l)The insured shall pay no application or processing fees of any kind.
(m)As part of its notification to the insured regarding a disposition of the insureds grievance that denies, modifies, or delays health care services, the insurer shall provide the insured with a one- or two-page application form approved by the department, and an addressed envelope, which the insured may return to initiate an independent medical review. The insurer shall include on the form any information required by the department to facilitate the completion of the independent medical review, such as the insureds diagnosis or condition, the nature of the disputed health care service sought by the insured, a means to identify the insureds case, and any other material information. The form shall also include the following:
(1)Notice that a decision not to participate in the independent review process may cause the insured to forfeit any statutory right to pursue legal action against the insurer regarding the disputed health care service.
(2)A statement indicating the insureds consent to obtain any necessary medical records from the insurer, any of its contracting providers, and any noncontracting provider the insured may have consulted on the matter, to be signed by the insured.
(3)Notice of the insureds right to provide information or documentation, either directly or through the insureds provider, regarding any of the following:
(A)A provider recommendation indicating that the disputed health care service is medically necessary for the insureds medical condition.
(B)Medical information or justification that a disputed health care service, on an urgent care or emergency basis, was medically necessary for the insureds medical condition.
(C)Reasonable information supporting the insureds position that the disputed health care service is or was medically necessary for the insureds medical condition, including all information provided to the insured by the insurer or any of its contracting providers, still in the possession of the insured, concerning an insurer or provider decision regarding disputed health care services, and a copy of any materials the insured submitted to the insurer, still in the possession of the insured, in support of the grievance, as well as any additional material that the insured believes is relevant.
(4)A section designed to collect information on the insureds ethnicity, race, and primary language spoken that includes both of the following:
(A)A statement of intent indicating that the information is used for statistics only, in order to ensure that all insureds get the best care possible.
(B)A statement indicating that providing this information is optional and will not affect the independent medical review process in any way.
(n)Upon notice from the department that the insured has applied for an independent medical review, the insurer or its contracting providers, shall provide to the independent medical review organization designated by the department a copy of all of the following documents within three business days of the insurers receipt of the departments notice of a request by an insured for an independent review:
(1)(A)A copy of all of the insureds medical records in the possession of the insurer or its contracting providers relevant to each of the following:
(i)The insureds medical condition.
(ii)The health care services being provided by the insurer and its contracting providers for the condition.
(iii)The disputed health care services requested by the insured for the condition.
(B)Any newly developed or discovered relevant medical records in the possession of the insurer or its contracting providers after the initial documents are provided to the independent medical review organization shall be forwarded immediately to the independent medical review organization. The insurer shall concurrently provide a copy of medical records required by this subparagraph to the insured or the insureds provider, if authorized by the insured, unless the offer of medical records is declined or otherwise prohibited by law. The confidentiality of all medical record information shall be maintained pursuant to applicable state and federal laws.
(2)A copy of all information provided to the insured by the insurer and any of its contracting providers concerning insurer and provider decisions regarding the insureds condition and care, and a copy of any materials the insured or the insureds provider submitted to the insurer and to the insurers contracting providers in support of the insureds request for disputed health care services. This documentation shall include the written response to the insureds grievance. The confidentiality of any insured medical information shall be maintained pursuant to applicable state and federal laws.
(3)A copy of any other relevant documents or information used by the insurer or its contracting providers in determining whether disputed health care services should have been provided, and any statements by the insurer and its contracting providers explaining the reasons for the decision to deny, modify, or delay disputed health care services on the basis of medical necessity. The insurer shall concurrently provide a copy of documents required by this paragraph, except for any information found by the commissioner to be legally privileged information, to the insured and the insureds provider. The department and the independent medical review organization shall maintain the confidentiality of any information found by the commissioner to be the proprietary information of the insurer.
SEC. 7.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Every health care service plan that provides prescription drug benefits shall maintain an expeditious process by which prescribing providers may obtain authorization for a medically necessary nonformulary prescription drug. On or before July 1, 1999, every health care service plan that provides prescription drug benefits shall file with the department a description of its process, including timelines, for responding to authorization requests for nonformulary drugs. Any changes to this process shall be filed with the department pursuant to Section 1352. Each plan shall provide a written description of its most current process, including timelines, to its prescribing providers. For purposes of this section, a prescribing provider shall include a provider authorized to write a prescription, pursuant to subdivision (a) of Section 4040 of the Business and Professions Code, to treat a medical condition of an enrollee.
(b)Any plan that disapproves a request made pursuant to subdivision (a) by a prescribing provider to obtain authorization for a nonformulary drug shall provide the reasons for the disapproval in a notice provided to the enrollee. The notice shall indicate that the enrollee may file a grievance with the plan if the enrollee objects to the disapproval, including any alternative drug or treatment offered by the plan. The notice shall comply with subdivision (b) of Section 1368.02. Any health plan that is required to maintain an external exception request review process pursuant to subdivision (k) shall indicate in the notice required under this subdivision that the enrollee may file file, in lieu of filing a grievance with the plan pursuant to Section 1368, a grievance seeking an external exception request review. An enrollee shall not be required to file a grievance with the plan or its contracting provider pursuant to Section 1368 if a plan disapproves a request to obtain authorization for a nonformulary drug under subdivision (a). If a plan disapproves a request to obtain authorization for a nonformulary drug and the enrollee files a grievance with the plan pursuant to Section 1368, the plan shall treat that request as a request to obtain an external exception request review.
(c)The process described in subdivision (a) by which prescribing providers may obtain authorization for medically necessary nonformulary drugs shall not apply to a nonformulary drug that has been prescribed for an enrollee in conformance with the provisions of Section 1367.22.
(d)The process described in subdivision (a) by which enrollees may obtain medically necessary nonformulary drugs, including specified timelines for responding to prescribing provider authorization requests, shall be described in evidence of coverage and disclosure forms, as required by subdivision (a) of Section 1363, issued on or after July 1, 1999.
(e)Every health care service plan that provides prescription drug benefits shall maintain, as part of its books and records under Section 1381, all of the following information, which shall be made available to the director upon request:
(1)The complete drug formulary or formularies of the plan, if the plan maintains a formulary, including a list of the prescription drugs on the formulary of the plan by major therapeutic category with an indication of whether any drugs are preferred over other drugs.
(2)Records developed by the pharmacy and therapeutic committee of the plan, or by others responsible for developing, modifying, and overseeing formularies, including medical groups, individual practice associations, and contracting pharmaceutical benefit management companies, used to guide the drugs prescribed for the enrollees of the plan, that fully describe the reasoning behind formulary decisions.
(3)Any plan arrangements with prescribing providers, medical groups, individual practice associations, pharmacists, contracting pharmaceutical benefit management companies, or other entities that are associated with activities of the plan to encourage formulary compliance or otherwise manage prescription drug benefits.
(f)If a plan provides prescription drug benefits, the department shall, as part of its periodic onsite medical survey of each plan undertaken pursuant to Section 1380, review the performance of the plan in providing those benefits, including, but not limited to, a review of the procedures and information maintained pursuant to this section, and describe the performance of the plan as part of its report issued pursuant to Section 1380.
(g)The director shall not publicly disclose any information reviewed pursuant to this section that is determined by the director to be confidential pursuant to state law.
(h)For purposes of this section, authorization means approval by the health care service plan to provide payment for the prescription drug.
(i)Nonformulary prescription drugs shall include any drug for which an enrollees copayment or out-of-pocket costs are different than the copayment for a formulary prescription drug, except as otherwise provided by law or regulation or in cases in which the drug has been excluded in the plan contract pursuant to Section 1342.7.
(j)Nothing in this section shall be construed to restrict or impair the application of any other provision of this chapter, including, but not limited to, Section 1367, which includes among its requirements that a health care service plan furnish services in a manner providing continuity of care and demonstrate that medical decisions are rendered by qualified medical providers unhindered by fiscal and administrative management.
(k)For any individual, small group, or large health plan contracts, a health care service plans process described in subdivision (a) shall comply with the request for exception and external exception request review processes described in subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations. This subdivision shall not apply to Medi-Cal managed care health care service plan contracts as described in subdivision (l).
(l)Medi-Cal managed care health care service plan contract means any entity that enters into a contract with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000), Chapter 8 (commencing with Section 14200), or Chapter 8.75 (commencing with Section 14591) of Part 3 of Division 9 of the Welfare and Institutions Code.
(m)Nothing in this section shall be construed to affect an enrollees or subscribers eligibility to submit a grievance to the department for review under Section 1368 or to apply to the department for an independent medical review under Section 1370.4, or Article 5.55 (commencing with Section 1374.30) of this chapter.
SEC. 2.Section 1368 of the Health and Safety Code is amended to read:1368.(a)Every plan shall do all of the following:
(1)Establish and maintain a grievance system approved by the department under which enrollees may submit their grievances to the plan. Each system shall provide reasonable procedures in accordance with department regulations that shall ensure adequate consideration of enrollee grievances and rectification when appropriate.
(2)Inform its subscribers and enrollees upon enrollment in the plan and annually thereafter of the procedure for processing and resolving grievances. The information shall include the location and telephone number where grievances may be submitted.
(3)Provide forms for grievances to be given to subscribers and enrollees who wish to register written grievances. The forms used by plans licensed pursuant to Section 1353 shall be approved by the director in advance as to format.
(4)(A)Provide for a written acknowledgment within five calendar days of the receipt of a grievance, except as noted in subparagraph (B). The acknowledgment shall advise the complainant of the following:
(i)That the grievance has been received.
(ii)The date of receipt.
(iii)The name of the plan representative and the telephone number and address of the plan representative who may be contacted about the grievance.
(B)(i)Grievances received by telephone, by facsimile, by email, or online through the plans Internet Web site pursuant to Section 1368.015, that are not coverage disputes, disputed health care services involving medical necessity, or experimental or investigational treatment and that are resolved by the next business day following receipt are exempt from the requirements of subparagraph (A) and paragraph (5). The plan shall maintain a log of all these grievances. The log shall be periodically reviewed by the plan and shall include the following information for each complaint:
(I)The date of the call.
(II)The name of the complainant.
(III)The complainants member identification number.
(IV)The nature of the grievance.
(V)The nature of the resolution.
(VI)The name of the plan representative who took the call and resolved the grievance.
(ii)For health plan contracts in the individual, small group, or large group markets, a health care service plans response to grievances subject to Section 1367.24 shall also comply with subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations. This paragraph shall not apply to Medi-Cal managed care health care service plan contracts or any entity that enters into a contract with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000), Chapter 8 (commencing with Section 14200), or Chapter 8.75 (commencing with Section 14591) of Part 3 of Division 9 of the Welfare and Institutions Code.
(5)Provide subscribers and enrollees with written responses to grievances, with a clear and concise explanation of the reasons for the plans response. For grievances involving the delay, denial, or modification of health care services, the plan response shall describe the criteria used and the clinical reasons for its decision, including all criteria and clinical reasons related to medical necessity. If a plan, or one of its contracting providers, issues a decision delaying, denying, or modifying health care services based in whole or in part on a finding that the proposed health care services are not a covered benefit under the contract that applies to the enrollee, the decision shall clearly specify the provisions in the contract that exclude that coverage.
(6)For grievances involving the cancellation, rescission, or nonrenewal of a health care service plan contract, the health care service plan shall continue to provide coverage to the enrollee or subscriber under the terms of the health care service plan contract until a final determination of the enrollees or subscribers request for review has been made by the health care service plan or the director pursuant to Section 1365 and this section. This paragraph shall not apply if the health care service plan cancels or fails to renew the enrollees or subscribers health care service plan contract for nonpayment of premiums pursuant to paragraph (1) of subdivision (a) of Section 1365.
(7)Keep in its files all copies of grievances, and the responses thereto, for a period of five years.
(b)(1)(A)After either completing the grievance process described in subdivision (a), or participating in the process for at least 30 days, or completing the external exception request review process described in subdivision (k) of Section 1367.24, a subscriber or enrollee may submit the grievance or external exception request review decision to the department for review. In any case under the grievance process determined by the department to be a case involving an imminent and serious threat to the health of the patient, including, but not limited to, severe pain, the potential loss of life, limb, or major bodily function, cancellations, rescissions, or the nonrenewal of a health care service plan contract, or in any other case where when the department determines that an earlier review is warranted, a subscriber or enrollee shall not be required to complete the grievance process or to participate in the process for at least 30 days before submitting a grievance to the department for review.
(B)A grievance or external exception request review decision may be submitted to the department for review and resolution prior to any arbitration.
(C)Notwithstanding subparagraphs (A) and (B), the department may refer any grievance or external exception request review decision that does not pertain to compliance with this chapter to the State Department of Public Health, the California Department of Aging, the federal Health Care Financing Administration, Centers for Medicare and Medicaid Services, or any other appropriate governmental entity for investigation and resolution.
(2)If the subscriber or enrollee is a minor, or is incompetent or incapacitated, the parent, guardian, conservator, relative, or other designee of the subscriber or enrollee, as appropriate, may submit the grievance or external exception request review decision to the department as the agent of the subscriber or enrollee. Further, a provider may join with, or otherwise assist, a subscriber or enrollee, or the agent, to submit the grievance or external exception request review decision to the department. In addition, following submission of the grievance or external exception request review decision to the department, the subscriber or enrollee, or the agent, may authorize the provider to assist, including advocating on behalf of the subscriber or enrollee. For purposes of this section, a relative includes the parent, stepparent, spouse, adult son or daughter, grandparent, brother, sister, uncle, or aunt of the subscriber or enrollee.
(3)The department shall review the written documents submitted with the subscribers or the enrollees request for review, or submitted by the agent on behalf of the subscriber or enrollee. The department may ask for additional information, and may hold an informal meeting with the involved parties, including providers who have joined in submitting the grievance or external exception request review decision or who are otherwise assisting or advocating on behalf of the subscriber or enrollee. If after reviewing the record, the department concludes that the grievance, grievance or external exception request review decision, in whole or in part, is eligible for review under the independent medical review system established pursuant to Article 5.55 (commencing with Section 1374.30), the department shall immediately notify the subscriber or enrollee, or agent, of that option and shall, if requested orally or in writing, assist the subscriber or enrollee in participating in the independent medical review system.
(4)If after reviewing the record of a grievance, grievance or external exception request review decision, the department concludes that a health care service eligible for coverage and payment under a health care service plan contract has been delayed, denied, or modified by a plan, or by one of its contracting providers, in whole or in part due to a determination that the service is not medically necessary, and that determination was not communicated to the enrollee in writing along with a notice of the enrollees potential right to participate in the independent medical review system, as required by this chapter, the director shall, by order, assess administrative penalties. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice of, and the opportunity for, a hearing with regard to the person affected in accordance with Section 1397. The administrative penalties shall not be deemed an exclusive remedy available to the director. These penalties shall be paid to the Managed Care Administrative Fines and Penalties Fund and shall be used for the purposes specified in Section 1341.45.
(5)The department shall send a written notice of the final disposition of the grievance, grievance or external exception request review decision, and the reasons therefor, to the subscriber or enrollee, the agent, to any provider that has joined with or is otherwise assisting the subscriber or enrollee, and to the plan, within 30 calendar days of receipt of the request for review unless the director, in his or her discretion, determines that additional time is reasonably necessary to fully and fairly evaluate the relevant grievance. grievance or external exception request review decision. In any case not eligible for the independent medical review system established pursuant to Article 5.55 (commencing with Section 1374.30), the departments written notice shall include, at a minimum, the following:
(A)A summary of its findings and the reasons why the department found the plan to be, or not to be, in compliance with any applicable laws, regulations, or orders of the director.
(B)A discussion of the departments contact with any medical provider, or any other independent expert relied on by the department, along with a summary of the views and qualifications of that provider or expert.
(C)If the enrollees grievance grievance or external exception request review decision is sustained in whole or in part, information about any corrective action taken.
(6)In any department review of a grievance or external exception request review decision involving a disputed health care service, as defined in subdivision (b) of Section 1374.30, that is not eligible for the independent medical review system established pursuant to Article 5.55 (commencing with Section 1374.30), in which the department finds that the plan has delayed, denied, or modified health care services that are medically necessary, based on the specific medical circumstances of the enrollee, and those services are a covered benefit under the terms and conditions of the health care service plan contract, the departments written notice shall do either of the following:
(A)Order the plan to promptly offer and provide those health care services to the enrollee.
(B)Order the plan to promptly reimburse the enrollee for any reasonable costs associated with urgent care or emergency services, or other extraordinary and compelling health care services, when the department finds that the enrollees decision to secure those services outside of the plan network was reasonable under the circumstances.
The departments order shall be binding on the plan.
(7)Distribution of the written notice shall not be deemed a waiver of any exemption or privilege under existing law, including, but not limited to, Section 6254.5 of the Government Code, for any information in connection with and including the written notice, nor shall any person employed or in any way retained by the department be required to testify as to that information or notice.
(8)The director shall establish and maintain a system of aging of grievances that are pending and unresolved for 30 days or more that shall include a brief explanation of the reasons each grievance is pending and unresolved for 30 days or more.
(9)A subscriber or enrollee, or the agent acting on behalf of a subscriber or enrollee, may also request voluntary mediation with the plan prior to exercising the right to submit a grievance or external exception request review decision to the department. The use of mediation services shall not preclude the right to submit a grievance or external exception request review decision to the department upon completion of mediation. In order to initiate mediation, the subscriber or enrollee, or the agent acting on behalf of the subscriber or enrollee, and the plan shall voluntarily agree to mediation. Expenses for mediation shall be borne equally by both sides. The department shall have no administrative or enforcement responsibilities in connection with the voluntary mediation process authorized by this paragraph.
(c)The plans grievance system shall include a system of aging of grievances that are pending and unresolved for 30 days or more. The plan shall provide a quarterly report to the director of grievances pending and unresolved for 30 or more days with separate categories of grievances for Medicare enrollees and Medi-Cal enrollees. The plan shall include with the report a brief explanation of the reasons each grievance is pending and unresolved for 30 days or more. The plan may include the following statement in the quarterly report that is made available to the public by the director:
Under Medicare and Medi-Cal law, Medicare enrollees and Medi-Cal enrollees each have separate avenues of appeal that are not available to other enrollees. Therefore, grievances pending and unresolved may reflect enrollees pursuing their Medicare or Medi-Cal appeal rights.
If requested by a plan, the director shall include this statement in a written report made available to the public and prepared by the director that describes or compares grievances that are pending and unresolved with the plan for 30 days or more. Additionally, the director shall, if requested by a plan, append to that written report a brief explanation, provided in writing by the plan, of the reasons why grievances described in that written report are pending and unresolved for 30 days or more. The director shall not be required to include a statement or append a brief explanation to a written report that the director is required to prepare under this chapter, including Sections 1380 and 1397.5.
(d)Subject to subparagraph (C) of paragraph (1) of subdivision (b), the grievance or resolution procedures authorized by this section shall be in addition to any other procedures that may be available to any person, and failure to pursue, exhaust, or engage in the procedures described in this section shall not preclude the use of any other remedy provided by law.
(e)Nothing in this section shall be construed to allow the submission to the department of any provider grievance under this section. However, as part of a providers duty to advocate for medically appropriate health care for his or her patients pursuant to Sections 510 and 2056 of the Business and Professions Code, nothing in this subdivision shall be construed to prohibit a provider from contacting and informing the department about any concerns he or she has regarding compliance with or enforcement of this chapter.
(f)To the extent required by Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations, there shall be an independent external review pursuant to the standards required by the United States Secretary of Health and Human Services of a health care service plans cancellation, rescission, or nonrenewal of an enrollees or subscribers coverage.
SEC. 3.Section 1368.01 of the Health and Safety Code is amended to read:1368.01.(a) The grievance system shall require the plan to resolve grievances within 30 days, except as provided in subdivision (c). subdivisions (c) and (d).
(b) The grievance system shall include a requirement for expedited plan review of grievances for cases involving an imminent and serious threat to the health of the patient, including, but not limited to, severe pain, potential loss of life, limb, or major bodily function. When the plan has notice of a case requiring expedited review, the grievance system shall require the plan to immediately inform enrollees and subscribers in writing of their right to notify the department of the grievance. The grievance system shall also require the plan to provide enrollees, subscribers, and the department with a written statement on the disposition or pending status of the grievance no later than three days from receipt of the grievance, except as provided in subdivision (c). Paragraph (4) of subdivision (a) of Section 1368 shall not apply to grievances handled pursuant to this section.
(c)A health care service plan contract in the individual, small group, or large group markets that provides coverage for outpatient prescription drugs shall comply with subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations. This subdivision shall not apply to Medi-Cal managed care health care service plan contracts or any entity that enters into a contract with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000), Chapter 8 (commencing with Section 14200), or Chapter 8.75 (commencing with Section 14591) of Part 3 of Division 9 of the Welfare and Institutions Code.
(d)The grievance system shall require a health care service plan that provides coverage for outpatient prescription drugs to resolve grievances within 72 hours for nonurgent requests, and within 24 hours if exigent circumstances exist, if the original request was an authorization for a formulary drug that requires prior authorization by the plan. For purposes of this subdivision, exigent circumstances shall have the same meaning as set forth in Section 1367.241.
SEC. 4.Section 1374.30 of the Health and Safety Code is amended to read:1374.30.(a)Commencing January 1, 2001, there is hereby established in the department the Independent Medical Review System.
(b)For the purposes of this chapter, disputed health care service means any health care service eligible for coverage and payment under a health care service plan contract that has been denied, modified, or delayed by a decision of the plan, or by one of its contracting providers, in whole or in part due to a finding that the service is not medically necessary. A decision regarding a disputed health care service relates to the practice of medicine and is not a coverage decision. A disputed health care service does not include services provided by a specialized health care service plan, except to the extent that the service (1) involves the practice of medicine, or (2) is provided pursuant to a contract with a health care service plan that covers hospital, medical, or surgical benefits. If a plan, or one of its contracting providers, issues a decision denying, modifying, or delaying health care services, based in whole or in part on a finding that the proposed health care services are not a covered benefit under the contract that applies to the enrollee, the statement of decision shall clearly specify the provision in the contract that excludes that coverage.
(c)For the purposes of this chapter, coverage decision means the approval or denial of health care services by a plan, or by one of its contracting entities, substantially based on a finding that the provision of a particular service is included or excluded as a covered benefit under the terms and conditions of the health care service plan contract. A coverage decision does not encompass a plan or contracting provider decision regarding a disputed health care service.
(d)(1)All enrollee grievances involving a disputed health care service are eligible for review under the Independent Medical Review System if the requirements of this article are met. If the department finds that an enrollee grievance involving a disputed health care service does not meet the requirements of this article for review under the Independent Medical Review System, the enrollee request for review shall be treated as a request for the department to review the grievance pursuant to subdivision (b) of Section 1368. All other enrollee grievances, including grievances involving coverage decisions, remain eligible for review by the department pursuant to subdivision (b) of Section 1368.
(2)In any case in which an enrollee or provider asserts that a decision to deny, modify, or delay health care services was based, in whole or in part, on consideration of medical necessity, the department shall have the final authority to determine whether the grievance is more properly resolved pursuant to an independent medical review as provided under this article or pursuant to subdivision (b) of Section 1368.
(3)The department shall be the final arbiter when there is a question as to whether an enrollee grievance is a disputed health care service or a coverage decision. The department shall establish a process to complete an initial screening of an enrollee grievance. If there appears to be any medical necessity issue, the grievance shall be resolved pursuant to an independent medical review as provided under this article or pursuant to subdivision (b) of Section 1368.
(e)Every health care service plan contract that is issued, amended, renewed, or delivered in this state on or after January 1, 2000, shall provide an enrollee with the opportunity to seek an independent medical review whenever health care services have been denied, modified, or delayed by the plan, or by one of its contracting providers, if the decision was based in whole or in part on a finding that the proposed health care services are not medically necessary. For purposes of this article, an enrollee may designate an agent to act on his or her behalf, as described in paragraph (2) of subdivision (b) of Section 1368. The provider may join with or otherwise assist the enrollee in seeking an independent medical review, and may advocate on behalf of the enrollee.
(f)Medi-Cal beneficiaries enrolled in a health care service plan shall not be excluded from participation. Medicare beneficiaries enrolled in a health care service plan shall not be excluded unless expressly preempted by federal law. Reviews of cases for Medi-Cal enrollees shall be conducted in accordance with statutes and regulations for the Medi-Cal program.
(g)The department may seek to integrate the quality of care and consumer protection provisions, including remedies, of the Independent Medical Review System with related dispute resolution procedures of other health care agency programs, including the Medicare and Medi-Cal programs, in a way that minimizes the potential for duplication, conflict, and added costs. Nothing in this subdivision shall be construed to limit any rights conferred upon enrollees under this chapter.
(h)The independent medical review process authorized by this article is in addition to any other procedures or remedies that may be available.
(i)Every health care service plan shall prominently display in every plan member handbook or relevant informational brochure, in every plan contract, on enrollee evidence of coverage forms, on copies of plan procedures for resolving grievances, on letters of denials issued by either the plan or its contracting organization, on the grievance forms required under Section 1368, and on all written responses to grievances, information concerning the right of an enrollee to request an independent medical review in cases where the enrollee believes that health care services have been improperly denied, modified, or delayed by the plan, or by one of its contracting providers.
(j)An enrollee may apply to the department for an independent medical review when all of the following conditions are met:
(1)(A)The enrollees provider has recommended a health care service as medically necessary, or necessary.
(B)The enrollee has received urgent care or emergency services that a provider determined was medically necessary, or necessary.
(C)The enrollee, in the absence of a provider recommendation under subparagraph (A) or the receipt of urgent care or emergency services by a provider under subparagraph (B), has been seen by an in-plan provider for the diagnosis or treatment of the medical condition for which the enrollee seeks independent review. The plan shall expedite access to an in-plan provider upon request of an enrollee. The in-plan provider need not recommend the disputed health care service as a condition for the enrollee to be eligible for an independent review.
For purposes of this article, the enrollees provider may be an out-of-plan provider. However, the plan shall have no liability for payment of services provided by an out-of-plan provider, except as provided pursuant to subdivision (c) of Section 1374.34.
(2)The disputed health care service has been denied, modified, or delayed by the plan, or by one of its contracting providers, based in whole or in part on a decision that the health care service is not medically necessary.
(3)Either of the following:
(3)
(A)The enrollee has filed a grievance with the plan or its contracting provider pursuant to Section 1368, and the disputed decision is upheld or the grievance remains unresolved after 30 days. The enrollee shall not be required to participate in the plans grievance process for more than 30 days. In the case of a grievance that requires expedited review pursuant to subdivision (b) of Section 1368.01, the enrollee shall not be required to participate in the plans grievance process for more than three days. In the case of a grievance that requires expedited review pursuant to subdivision (d) of Section 1368.01, the enrollee shall not be required to participate in the plans grievance process for more than 72 hours, or more than 24 hours if exigent circumstances exist.
(B)The enrollee has filed for an external exception request review decision with the plan or its contracting provider pursuant to subdivision (k) of Section 1367.24, and the disputed decision is upheld or the external review remains unresolved after 72 hours, or after 24 hours if exigent circumstances exist.
(k)An enrollee may apply to the department for an independent medical review of a decision to deny, modify, or delay health care services, based in whole or in part on a finding that the disputed health care services are not medically necessary, within six months of any of the qualifying periods or events under subdivision (j). The director may extend the application deadline beyond six months if the circumstances of a case warrant the extension.
(l)The enrollee shall pay no application or processing fees of any kind.
(m)As part of its notification to the enrollee regarding a disposition of the enrollees grievance that denies, modifies, or delays health care services, the plan shall provide the enrollee with a one- or two-page application form approved by the department, and an addressed envelope, which the enrollee may return to initiate an independent medical review. The plan shall include on the form any information required by the department to facilitate the completion of the independent medical review, such as the enrollees diagnosis or condition, the nature of the disputed health care service sought by the enrollee, a means to identify the enrollees case, and any other material information. The form shall also include the following:
(1)Notice that a decision not to participate in the independent medical review process may cause the enrollee to forfeit any statutory right to pursue legal action against the plan regarding the disputed health care service.
(2)A statement indicating the enrollees consent to obtain any necessary medical records from the plan, any of its contracting providers, and any out-of-plan provider the enrollee may have consulted on the matter, to be signed by the enrollee.
(3)Notice of the enrollees right to provide information or documentation, either directly or through the enrollees provider, regarding any of the following:
(A)A provider recommendation indicating that the disputed health care service is medically necessary for the enrollees medical condition.
(B)Medical information or justification that a disputed health care service, on an urgent care or emergency basis, was medically necessary for the enrollees medical condition.
(C)Reasonable information supporting the enrollees position that the disputed health care service is or was medically necessary for the enrollees medical condition, including all information provided to the enrollee by the plan or any of its contracting providers, still in the possession of the enrollee, concerning a plan or provider decision regarding disputed health care services, and a copy of any materials the enrollee submitted to the plan, still in the possession of the enrollee, in support of the grievance, as well as any additional material that the enrollee believes is relevant.
(4)A section designed to collect information on the enrollees ethnicity, race, and primary language spoken that includes both of the following:
(A)A statement of intent indicating that the information is used for statistics only, in order to ensure that all enrollees get the best care possible.
(B)A statement indicating that providing this information is optional and will not affect the independent medical review process in any way.
(n)Upon notice from the department that the health care service plans enrollee has applied for an independent medical review, the plan or its contracting providers shall provide to the independent medical review organization designated by the department a copy of all of the following documents within three business days of the plans receipt of the departments notice of a request by an enrollee for an independent review:
(1)(A)A copy of all of the enrollees medical records in the possession of the plan or its contracting providers relevant to each of the following:
(i)The enrollees medical condition.
(ii)The health care services being provided by the plan and its contracting providers for the condition.
(iii)The disputed health care services requested by the enrollee for the condition.
(B)Any newly developed or discovered relevant medical records in the possession of the plan or its contracting providers after the initial documents are provided to the independent medical review organization shall be forwarded immediately to the independent medical review organization. The plan shall concurrently provide a copy of medical records required by this subparagraph to the enrollee or the enrollees provider, if authorized by the enrollee, unless the offer of medical records is declined or otherwise prohibited by law. The confidentiality of all medical record information shall be maintained pursuant to applicable state and federal laws.
(2)A copy of all information provided to the enrollee by the plan and any of its contracting providers concerning plan and provider decisions regarding the enrollees condition and care, and a copy of any materials the enrollee or the enrollees provider submitted to the plan and to the plans contracting providers in support of the enrollees request for disputed health care services. This documentation shall include the written response to the enrollees grievance, required by paragraph (4) of subdivision (a) of Section 1368. The confidentiality of any enrollee medical information shall be maintained pursuant to applicable state and federal laws.
(3)A copy of any other relevant documents or information used by the plan or its contracting providers in determining whether disputed health care services should have been provided, and any statements by the plan and its contracting providers explaining the reasons for the decision to deny, modify, or delay disputed health care services on the basis of medical necessity. The plan shall concurrently provide a copy of documents required by this paragraph, except for any information found by the director to be legally privileged information, to the enrollee and the enrollees provider. The department and the independent medical review organization shall maintain the confidentiality of any information found by the director to be the proprietary information of the plan.
(o)This section shall become operative on July 1, 2015.
SEC. 5.Section 10123.191 of the Insurance Code is amended to read:10123.191.(a)Notwithstanding any other law, on and after January 1, 2013, a health insurer that provides coverage for prescription drugs shall utilize and accept only the prior authorization form developed pursuant to subdivision (c), or an electronic prior authorization process described in subdivision (e), when requiring prior authorization for prescription drugs.
(b)(1)If a health insurer or a contracted physician group fails to respond within 72 hours for nonurgent requests, and within 24 hours if exigent circumstances exist, upon receipt of a completed prior authorization request from a prescribing provider, the prior authorization request shall be deemed to have been granted.
(2)A health insurers internal grievance process shall require a health insurer that provides coverage for outpatient prescription drugs to resolve grievances within 72 hours for nonurgent requests, and within 24 hours if exigent circumstances exist, if the original request was an authorization for a formulary drug that requires prior authorization by the health insurer.
(c)On or before January 1, 2017, the department and the Department of Managed Health Care shall jointly develop a uniform prior authorization form. Notwithstanding any other law, on and after July 1, 2017, or six months after the form is completed pursuant to this section, whichever is later, every prescribing provider shall use that uniform prior authorization form, or an electronic prior authorization process described in subdivision (e), to request prior authorization for coverage of prescription drugs and every health insurer shall accept that form or electronic process as sufficient to request prior authorization for prescription drugs.
(d)The prior authorization form developed pursuant to subdivision (c) shall meet the following criteria:
(1)The form shall not exceed two pages.
(2)The form shall be made electronically available by the department and the health insurer.
(3)The completed form may also be electronically submitted from the prescribing provider to the health insurer.
(4)The department and the Department of Managed Health Care shall develop the form with input from interested parties from at least one public meeting.
(5)The department and the Department of Managed Health Care, in development of the standardized form, shall take into consideration the following:
(A)Existing prior authorization forms established by the federal Centers for Medicare and Medicaid Services and the State Department of Health Care Services.
(B)National standards pertaining to electronic prior authorization.
(e)A prescribing provider may use an electronic prior authorization system utilizing the standardized form described in subdivision (c) or an electronic process developed specifically for transmitting prior authorization information that meets the National Council for Prescription Drug Programs SCRIPT standard for electronic prior authorization transactions.
(f)Subdivision (a) does not apply if any of the following occurs:
(1)A contracted physician group is delegated the financial risk for the pharmacy or medical drug benefit by a health insurer.
(2)A contracted physician group uses its own internal prior authorization process rather than the health insurers prior authorization process for the health insurers insureds.
(3)A contracted physician group is delegated a utilization management function by the health insurer concerning any prescription drug, regardless of the delegation of financial risk.
(g)For prescription drugs, prior authorization requirements described in subdivisions (c) and (e) apply regardless of how that benefit is classified under the terms of the health insurers group or individual policy.
(h)(1)A health insurer shall maintain a process for an external exception request review that complies with subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations.
(2)An insured shall not be required to file a complaint with the health insurer or its contracting provider pursuant to its internal grievance process if a health insurer disapproves a request to obtain authorization for a nonformulary drug under subdivision (i). If a health insurer disapproves a request to obtain authorization for a nonformulary drug and the insured files a complaint with the health insurer, the health insurer shall treat that as a request to obtain an external exception request review.
(i)For an individual, small group, or large group health insurance policy, a health insurer that provides coverage for outpatient prescription drugs shall comply with subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations.
(j)Nothing in this section shall be construed to affect an insureds or policyholders eligibility to submit a complaint to the department for review or to apply to the department for an independent medical review under Article 3.5 (commencing with Section 10169).
(j)
(k)For purposes of this section:
(1)Prescribing provider shall include a provider authorized to write a prescription, pursuant to subdivision (a) of Section 4040 of the Business and Professions Code, to treat a medical condition of an insured.
(2)Exigent circumstances exist when an insured is suffering from a health condition that may seriously jeopardize the insureds life, health, or ability to regain maximum function or when an insured is undergoing a current course of treatment using a nonformulary drug.
(3)Completed prior authorization request means a completed uniform prior authorization form developed pursuant to subdivision (c), or a completed request submitted using an electronic prior authorization system described in subdivision (e), or, for contracted physician groups described in subdivision (f), the process used by the contracted physician group.
SEC. 6.Section 10169 of the Insurance Code, as added by Section 19 of Chapter 348 of the Statutes of 2015, is amended to read:10169.(a)Commencing January 1, 2001, there is hereby established in the department the Independent Medical Review System.
(b)For the purposes of this chapter, disputed health care service means any health care service eligible for coverage and payment under a disability insurance contract that has been denied, modified, or delayed by a decision of the insurer, or by one of its contracting providers, in whole or in part due to a finding that the service is not medically necessary. A decision regarding a disputed health care service relates to the practice of medicine and is not a coverage decision. A disputed health care service does not include services provided by a group or individual policy of vision-only or dental-only coverage, except to the extent that (1) the service involves the practice of medicine, or (2) is provided pursuant to a contract with a disability insurer that covers hospital, medical, or surgical benefits. If an insurer, or one of its contracting providers, issues a decision denying, modifying, or delaying health care services, based in whole or in part on a finding that the proposed health care services are not a covered benefit under the contract that applies to the insured, the statement of decision shall clearly specify the provision in the contract that excludes that coverage.
(c)For the purposes of this chapter, coverage decision means the approval or denial of health care services by a disability insurer, or by one of its contracting entities, substantially based on a finding that the provision of a particular service is included or excluded as a covered benefit under the terms and conditions of the disability insurance contract. A coverage decision does not encompass a disability insurer or contracting provider decision regarding a disputed health care service.
(d)(1)All insured grievances involving a disputed health care service are eligible for review under the Independent Medical Review System if the requirements of this article are met. If the department finds that an insured grievance involving a disputed health care service does not meet the requirements of this article for review under the Independent Medical Review System, the insured request for review shall be treated as a request for the department to review the grievance. All other insured grievances, including grievances involving coverage decisions, remain eligible for review by the department.
(2)In any case in which an insured or provider asserts that a decision to deny, modify, or delay health care services was based, in whole or in part, on consideration of medical necessity, the department shall have the final authority to determine whether the grievance is more properly resolved pursuant to an independent medical review as provided under this article.
(3)The department shall be the final arbiter when there is a question as to whether an insured grievance is a disputed health care service or a coverage decision. The department shall establish a process to complete an initial screening of an insured grievance. If there appears to be any medical necessity issue, the grievance shall be resolved pursuant to an independent medical review as provided under this article.
(e)Every disability insurance contract that is issued, amended, renewed, or delivered in this state on or after January 1, 2000, shall provide an insured with the opportunity to seek an independent medical review whenever health care services have been denied, modified, or delayed by the insurer, or by one of its contracting providers, if the decision was based in whole or in part on a finding that the proposed health care services are not medically necessary. For purposes of this article, an insured may designate an agent to act on his or her behalf. The provider may join with or otherwise assist the insured in seeking an independent medical review, and may advocate on behalf of the insured.
(f)Medicare beneficiaries enrolled in Medicare + Choice products shall not be excluded unless expressly preempted by federal law.
(g)The department may seek to integrate the quality of care and consumer protection provisions, including remedies, of the Independent Medical Review System with related dispute resolution procedures of other health care agency programs, including the Medicare program, in a way that minimizes the potential for duplication, conflict, and added costs. Nothing in this subdivision shall be construed to limit any rights conferred upon insureds under this chapter.
(h)The independent medical review process authorized by this article is in addition to any other procedures or remedies that may be available.
(i)Every disability insurer shall prominently display in every insurer member handbook or relevant informational brochure, in every insurance contract, on insured evidence of coverage forms, on copies of insurer procedures for resolving grievances, on letters of denials issued by either the insurer or its contracting organization, and on all written responses to grievances, information concerning the right of an insured to request an independent medical review when the insured believes that health care services have been improperly denied, modified, or delayed by the insurer, or by one of its contracting providers. The departments telephone number, 1-800-927-4357, and Internet Web site, www.insurance.ca.gov, shall also be displayed.
(j)An insured may apply to the department for an independent medical review when all of the following conditions are met:
(1)(A)The insureds provider has recommended a health care service as medically necessary, or
(B)The insured has received urgent care or emergency services that a provider determined was medically necessary, or
(C)The insured, in the absence of a provider recommendation under subparagraph (A) or the receipt of urgent care or emergency services by a provider under subparagraph (B), has been seen by a contracting provider for the diagnosis or treatment of the medical condition for which the insured seeks independent review. The insurer shall expedite access to a contracting provider upon request of an insured. The contracting provider need not recommend the disputed health care service as a condition for the insured to be eligible for an independent review.
For purposes of this article, the insureds provider may be a noncontracting provider. However, the insurer shall have no liability for payment of services provided by a noncontracting provider, except as provided pursuant to Section 10169.3.
(2)The disputed health care service has been denied, modified, or delayed by the insurer, or by one of its contracting providers, based in whole or in part on a decision that the health care service is not medically necessary.
(3)Either of the following:
(3)
(A)The insured has filed a grievance with the insurer or its contracting provider, and the disputed decision is upheld or the grievance remains unresolved after 30 days. The insured shall not be required to participate in the insurers grievance process for more than 30 days. In the case of a grievance that requires expedited review, the insured shall not be required to participate in the insurers grievance process for more than three days. In the case of a grievance that requires expedited review pursuant to paragraph (2) of subdivision (b) of Section 10123.191, the insured shall not be required to participate in the insureds grievance process for more than 72 hours, or more than 24 hours if exigent circumstances exist.
(B)The insured has filed for an external exception request review decision with the insurer or its contracting provider pursuant to subdivision (h) of Section 10123.191, and the disputed decision is upheld or the external review remains unresolved after 72 hours, or after 24 hours if exigent circumstances exist.
(k)An insured may apply to the department for an independent medical review of a decision to deny, modify, or delay health care services, based in whole or in part on a finding that the disputed health care services are not medically necessary, within six months of any of the qualifying periods or events under subdivision (j). The commissioner may extend the application deadline beyond six months if the circumstances of a case warrant the extension.
(l)The insured shall pay no application or processing fees of any kind.
(m)As part of its notification to the insured regarding a disposition of the insureds grievance that denies, modifies, or delays health care services, the insurer shall provide the insured with a one- or two-page application form approved by the department, and an addressed envelope, which the insured may return to initiate an independent medical review. The insurer shall include on the form any information required by the department to facilitate the completion of the independent medical review, such as the insureds diagnosis or condition, the nature of the disputed health care service sought by the insured, a means to identify the insureds case, and any other material information. The form shall also include the following:
(1)Notice that a decision not to participate in the independent review process may cause the insured to forfeit any statutory right to pursue legal action against the insurer regarding the disputed health care service.
(2)A statement indicating the insureds consent to obtain any necessary medical records from the insurer, any of its contracting providers, and any noncontracting provider the insured may have consulted on the matter, to be signed by the insured.
(3)Notice of the insureds right to provide information or documentation, either directly or through the insureds provider, regarding any of the following:
(A)A provider recommendation indicating that the disputed health care service is medically necessary for the insureds medical condition.
(B)Medical information or justification that a disputed health care service, on an urgent care or emergency basis, was medically necessary for the insureds medical condition.
(C)Reasonable information supporting the insureds position that the disputed health care service is or was medically necessary for the insureds medical condition, including all information provided to the insured by the insurer or any of its contracting providers, still in the possession of the insured, concerning an insurer or provider decision regarding disputed health care services, and a copy of any materials the insured submitted to the insurer, still in the possession of the insured, in support of the grievance, as well as any additional material that the insured believes is relevant.
(4)A section designed to collect information on the insureds ethnicity, race, and primary language spoken that includes both of the following:
(A)A statement of intent indicating that the information is used for statistics only, in order to ensure that all insureds get the best care possible.
(B)A statement indicating that providing this information is optional and will not affect the independent medical review process in any way.
(n)Upon notice from the department that the insured has applied for an independent medical review, the insurer or its contracting providers, shall provide to the independent medical review organization designated by the department a copy of all of the following documents within three business days of the insurers receipt of the departments notice of a request by an insured for an independent review:
(1)(A)A copy of all of the insureds medical records in the possession of the insurer or its contracting providers relevant to each of the following:
(i)The insureds medical condition.
(ii)The health care services being provided by the insurer and its contracting providers for the condition.
(iii)The disputed health care services requested by the insured for the condition.
(B)Any newly developed or discovered relevant medical records in the possession of the insurer or its contracting providers after the initial documents are provided to the independent medical review organization shall be forwarded immediately to the independent medical review organization. The insurer shall concurrently provide a copy of medical records required by this subparagraph to the insured or the insureds provider, if authorized by the insured, unless the offer of medical records is declined or otherwise prohibited by law. The confidentiality of all medical record information shall be maintained pursuant to applicable state and federal laws.
(2)A copy of all information provided to the insured by the insurer and any of its contracting providers concerning insurer and provider decisions regarding the insureds condition and care, and a copy of any materials the insured or the insureds provider submitted to the insurer and to the insurers contracting providers in support of the insureds request for disputed health care services. This documentation shall include the written response to the insureds grievance. The confidentiality of any insured medical information shall be maintained pursuant to applicable state and federal laws.
(3)A copy of any other relevant documents or information used by the insurer or its contracting providers in determining whether disputed health care services should have been provided, and any statements by the insurer and its contracting providers explaining the reasons for the decision to deny, modify, or delay disputed health care services on the basis of medical necessity. The insurer shall concurrently provide a copy of documents required by this paragraph, except for any information found by the commissioner to be legally privileged information, to the insured and the insureds provider. The department and the independent medical review organization shall maintain the confidentiality of any information found by the commissioner to be the proprietary information of the insurer.
(o)This section shall become operative on January 1, 2017.
SEC. 7.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
SECTION 1.Section 1367.24 of the Health and Safety Code is amended to read:1367.24.(a)(1)Every health care service plan that provides prescription drug benefits shall maintain an expeditious process, as described in this subdivision, by which enrollees, enrollees designees, or prescribing providers may request and obtain authorization for medically necessary nonformulary prescription drugs and medically necessary formulary prescription drugs that require prior authorization by the plan. The plan shall provide that the enrollee, the enrollees designee, or the enrollees prescribing provider may seek a prior authorization for a prescription drug under this subdivision.
(2)Each plan shall respond to a prior authorization request within 72 hours following receipt of the prior authorization request. A plan that grants a prior authorization request under this paragraph shall provide coverage of the prescription drug for the duration of the prescription, including refills.
(3)Each plan shall provide that a prior authorization may be obtained within 24 hours if an enrollee is suffering from a health condition that may seriously jeopardize the enrollees life, health, or ability to regain maximum function or if an enrollee is undergoing a current course of treatment using a nonformulary drug. A plan that grants a prior authorization request under this paragraph based on exigent circumstances shall provide coverage of the prescription drug for the duration of the exigency.
(4)If a plan fails to respond within 72 hours for a prior authorization request, or within 24 hours if exigent circumstances exist, upon receipt of a completed prior authorization request, the prior authorization request shall be deemed to have been granted.
(5)Each plan shall provide a written description of the process described in paragraph (1) to its prescribing providers. For purposes of this section, a prescribing provider shall include a provider authorized to write a prescription, pursuant to subdivision (a) of Section 4040 of the Business and Professions Code, to treat a medical condition of an enrollee.
(b)If a plan disapproves a prior authorization request made pursuant to subdivision (a), the plan shall maintain an expeditious process to authorize an enrollee to obtain an external review.
(1)A determination on an external review shall be made no later than 72 hours following receipt of the request, if the original request was an authorization request under paragraph (2) of subdivision (a), and no later than 24 hours following receipt of the request, if the original request was an authorization request under paragraph (3) of subdivision (a).
(2)If an external review decision of a prior authorization request under paragraph (2) of subdivision (a) is granted, the plan shall provide coverage of the prescription drug for the duration of the prescription, including refills. If an external review decision of a prior authorization request under paragraph (3) of subdivision (a) is granted, the plan shall provide coverage of the prescription drug for the duration of the exigency.
(c)Any plan that disapproves a request made pursuant to subdivision (a) to obtain authorization for a nonformulary or formulary drug shall provide the reasons for the disapproval in a notice provided to the enrollee. The notice shall indicate that the enrollee may file, in lieu of filing a grievance with the plan, a request for an external review pursuant to subdivision (b) if the enrollee objects to the disapproval, including any alternative drug or treatment offered by the plan. The notice shall comply with subdivision (b) of Section 1368.02. If a plan disapproves a request made pursuant to subdivision (a), an enrollee shall not be required to file a grievance with the plan or its contracting provider pursuant to Section 1368.
(d)The process described in subdivisions (a) and (b) by which enrollees, enrollees designees, and prescribing providers may obtain authorization for medically necessary nonformulary drugs shall not apply to a nonformulary drug that has been prescribed for an enrollee in conformance with the provisions of Section 1367.22.
(e)The process described in subdivisions (a) and (b) by which enrollees may obtain medically necessary nonformulary drugs and formulary drugs shall be described in evidence of coverage and disclosure forms, as required by subdivision (a) of Section 1363, issued on or after July 1, 2017.
(f)Every health care service plan that provides prescription drug benefits shall maintain, as part of its books and records under Section 1381, all of the following information, which shall be made available to the director upon request:
(1)The complete drug formulary or formularies of the plan, if the plan maintains a formulary, including a list of the prescription drugs on the formulary of the plan by major therapeutic category with an indication of whether any drugs are preferred over other drugs.
(2)Records developed by the pharmacy and therapeutic committee of the plan, or by others responsible for developing, modifying, and overseeing formularies, including medical groups, individual practice associations, and contracting pharmaceutical benefit management companies, used to guide the drugs prescribed for the enrollees of the plan, that fully describe the reasoning behind formulary decisions.
(3)Any plan arrangements with prescribing providers, medical groups, individual practice associations, pharmacists, contracting pharmaceutical benefit management companies, or other entities that are associated with activities of the plan to encourage formulary compliance or otherwise manage prescription drug benefits.
(g)If a plan provides prescription drug benefits, the department shall, as part of its periodic onsite medical survey of each plan undertaken pursuant to Section 1380, review the performance of the plan in providing those benefits, including, but not limited to, a review of the procedures and information maintained pursuant to this section, and describe the performance of the plan as part of its report issued pursuant to Section 1380.
(h)The director shall not publicly disclose any information reviewed pursuant to this section that is determined by the director to be confidential pursuant to state law.
(i)For purposes of this section, authorization means approval by the health care service plan to provide payment for the prescription drug.
(j)Nonformulary prescription drugs shall include any drug for which an enrollees copayment or out-of-pocket costs are different than the copayment for a formulary prescription drug, except as otherwise provided by law or regulation or in cases in which the drug has been excluded in the plan contract pursuant to Section 1342.7.
(k)Nothing in this section shall be construed to restrict or impair the application of any other provision of this chapter, including, but not limited to, Section 1367, which includes among its requirements that a health care service plan furnish services in a manner providing continuity of care and demonstrate that medical decisions are rendered by qualified medical providers unhindered by fiscal and administrative management.
(l)A health care service plan contract in the individual, small group, and large group markets that provides coverage for outpatient prescription drugs shall comply with this section. This section shall not apply to Medi-Cal managed care health care service plan contracts.
(m)Medi-Cal managed care health care service plan contract means any entity that enters into a contract with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000), Chapter 8 (commencing with Section 14200), or Chapter 8.75 (commencing with Section 14591) of Part 3 of Division 9 of the Welfare and Institutions Code.
(n)Nothing in this section shall be construed to affect an enrollees or subscribers eligibility to submit a grievance to the department for review under Section 1368 or to apply to the department for an independent medical review under Section 1370.4, or Article 5.55 (commencing with Section 1374.30) of this chapter.
SEC. 2.Section 1367.241 of the Health and Safety Code is amended to read:1367.241.(a)Notwithstanding any other law, on and after January 1, 2013, a health care service plan that provides coverage for prescription drugs shall accept only the prior authorization form developed pursuant to subdivision (b), or an electronic prior authorization process described in subdivision (d), when requiring prior authorization for prescription drugs. This section does not apply in the event that a physician or physician group has been delegated the financial risk for prescription drugs by a health care service plan and does not use a prior authorization process. This section does not apply to a health care service plan, or to its affiliated providers, if the health care service plan owns and operates its pharmacies and does not use a prior authorization process for prescription drugs.
(b)On or before January 1, 2017, the department and the Department of Insurance shall jointly develop a uniform prior authorization form. Notwithstanding any other law, on and after July 1, 2017, or six months after the form is completed pursuant to this section, whichever is later, every prescribing provider shall use that uniform prior authorization form, or an electronic prior authorization process described in subdivision (d), to request prior authorization for coverage of prescription drugs and every health care service plan shall accept that form or electronic process as sufficient to request prior authorization for prescription drugs.
(c)The prior authorization form developed pursuant to subdivision (b) shall meet the following criteria:
(1)The form shall not exceed two pages.
(2)The form shall be made electronically available by the department and the health care service plan.
(3)The completed form may also be electronically submitted from the prescribing provider to the health care service plan.
(4)The department and the Department of Insurance shall develop the form with input from interested parties from at least one public meeting.
(5)The department and the Department of Insurance, in development of the standardized form, shall take into consideration the following:
(A)Existing prior authorization forms established by the federal Centers for Medicare and Medicaid Services and the State Department of Health Care Services.
(B)National standards pertaining to electronic prior authorization.
(d)A prescribing provider may use an electronic prior authorization system utilizing the standardized form described in subdivision (b) or an electronic process developed specifically for transmitting prior authorization information that meets the National Council for Prescription Drug Programs SCRIPT standard for electronic prior authorization transactions.
(e)Subdivision (a) does not apply if any of the following occurs:
(1)A contracted physician group is delegated the financial risk for prescription drugs by a health care service plan.
(2)A contracted physician group uses its own internal prior authorization process rather than the health care service plans prior authorization process for plan enrollees.
(3)A contracted physician group is delegated a utilization management function by the health care service plan concerning any prescription drug, regardless of the delegation of financial risk.
(f)For prescription drugs, prior authorization requirements described in subdivisions (b) and (d) apply regardless of how that benefit is classified under the terms of the health plans group or individual contract.
(g)For purposes of this section:
(1)Prescribing provider shall include a provider authorized to write a prescription, pursuant to subdivision (a) of Section 4040 of the Business and Professions Code, to treat a medical condition of an enrollee.
(2)Completed prior authorization request means a completed uniform prior authorization form developed pursuant to subdivision (b), or a completed request submitted using an electronic prior authorization system described in subdivision (d), or, for contracted physician groups described in subdivision (e), the process used by the contracted physician group.
SEC. 3.Section 1367.244 of the Health and Safety Code is amended to read:1367.244.(a)A request for an exception to a health care service plans step therapy process for prescription drugs may be submitted in the same manner as a request for prior authorization for prescription drugs pursuant to Section 1367.24, and shall be treated in the same manner, and shall be responded to by the health care service plan in the same manner, as a request for prior authorization for prescription drugs.
(b)The department and the Department of Insurance shall include a provision for step therapy exception requests in the uniform prior authorization form developed pursuant to subdivision (b) of Section 1367.241.
SEC. 4.Section 1368 of the Health and Safety Code is amended to read:1368.(a)Every plan shall do all of the following:
(1)Establish and maintain a grievance system approved by the department under which enrollees may submit their grievances to the plan. Each system shall provide reasonable procedures in accordance with department regulations that shall ensure adequate consideration of enrollee grievances and rectification when appropriate.
(2)Inform its subscribers and enrollees upon enrollment in the plan and annually thereafter of the procedure for processing and resolving grievances. The information shall include the location and telephone number where grievances may be submitted.
(3)Provide forms for grievances to be given to subscribers and enrollees who wish to register written grievances. The forms used by plans licensed pursuant to Section 1353 shall be approved by the director in advance as to format.
(4)(A)Provide for a written acknowledgment within five calendar days of the receipt of a grievance, except as noted in subparagraph (B). The acknowledgment shall advise the complainant of the following:
(i)That the grievance has been received.
(ii)The date of receipt.
(iii)The name of the plan representative and the telephone number and address of the plan representative who may be contacted about the grievance.
(B)Grievances received by telephone, by facsimile, by email, or online through the plans Internet Web site pursuant to Section 1368.015, that are not coverage disputes, disputed health care services involving medical necessity, or experimental or investigational treatment and that are resolved by the next business day following receipt are exempt from the requirements of subparagraph (A) and paragraph (5). The plan shall maintain a log of all these grievances. The log shall be periodically reviewed by the plan and shall include the following information for each complaint:
(i)The date of the call.
(ii)The name of the complainant.
(iii)The complainants member identification number.
(iv)The nature of the grievance.
(v)The nature of the resolution.
(vi)The name of the plan representative who took the call and resolved the grievance.
(5)Provide subscribers and enrollees with written responses to grievances, with a clear and concise explanation of the reasons for the plans response. For grievances involving the delay, denial, or modification of health care services, the plan response shall describe the criteria used and the clinical reasons for its decision, including all criteria and clinical reasons related to medical necessity. If a plan, or one of its contracting providers, issues a decision delaying, denying, or modifying health care services based in whole or in part on a finding that the proposed health care services are not a covered benefit under the contract that applies to the enrollee, the decision shall clearly specify the provisions in the contract that exclude that coverage.
(6)For grievances involving the cancellation, rescission, or nonrenewal of a health care service plan contract, the health care service plan shall continue to provide coverage to the enrollee or subscriber under the terms of the health care service plan contract until a final determination of the enrollees or subscribers request for review has been made by the health care service plan or the director pursuant to Section 1365 and this section. This paragraph shall not apply if the health care service plan cancels or fails to renew the enrollees or subscribers health care service plan contract for nonpayment of premiums pursuant to paragraph (1) of subdivision (a) of Section 1365.
(7)Keep in its files all copies of grievances, and the responses thereto, for a period of five years.
(b)(1)(A)After either completing the grievance process described in subdivision (a), participating in the process for at least 30 days, or completing the external review process described in subdivision (b) of Section 1367.24, a subscriber or enrollee may submit the grievance or external review decision to the department for review. In any case under the grievance process determined by the department to be a case involving an imminent and serious threat to the health of the patient, including, but not limited to, severe pain, the potential loss of life, limb, or major bodily function, cancellations, rescissions, or the nonrenewal of a health care service plan contract, or in any other case where the department determines that an earlier review is warranted, a subscriber or enrollee shall not be required to complete the grievance process or to participate in the process for at least 30 days before submitting a grievance to the department for review.
(B)A grievance or external review decision may be submitted to the department for review and resolution prior to any arbitration.
(C)Notwithstanding subparagraphs (A) and (B), the department may refer any grievance or external review decision that does not pertain to compliance with this chapter to the State Department of Public Health, the California Department of Aging, the federal Centers for Medicare and Medicaid Services, or any other appropriate governmental entity for investigation and resolution.
(2)If the subscriber or enrollee is a minor, or is incompetent or incapacitated, the parent, guardian, conservator, relative, or other designee of the subscriber or enrollee, as appropriate, may submit the grievance or external review decision to the department as the agent of the subscriber or enrollee. Further, a provider may join with, or otherwise assist, a subscriber or enrollee, or the agent, to submit the grievance or external review decision to the department. In addition, following submission of the grievance or external review decision to the department, the subscriber or enrollee, or the agent, may authorize the provider to assist, including advocating on behalf of the subscriber or enrollee. For purposes of this section, a relative includes the parent, stepparent, spouse, adult son or daughter, grandparent, brother, sister, uncle, or aunt of the subscriber or enrollee.
(3)The department shall review the written documents submitted with the subscribers or the enrollees request for review, or submitted by the agent on behalf of the subscriber or enrollee. The department may ask for additional information, and may hold an informal meeting with the involved parties, including providers who have joined in submitting the grievance or external review decision or who are otherwise assisting or advocating on behalf of the subscriber or enrollee. If after reviewing the record, the department concludes that the grievance or external review decision, in whole or in part, is eligible for review under the independent medical review system established pursuant to Article 5.55 (commencing with Section 1374.30), the department shall immediately notify the subscriber or enrollee, or agent, of that option and shall, if requested orally or in writing, assist the subscriber or enrollee in participating in the independent medical review system.
(4)If after reviewing the record of a grievance or external review decision, the department concludes that a health care service eligible for coverage and payment under a health care service plan contract has been delayed, denied, or modified by a plan, or by one of its contracting providers, in whole or in part due to a determination that the service is not medically necessary, and that determination was not communicated to the enrollee in writing along with a notice of the enrollees potential right to participate in the independent medical review system, as required by this chapter, the director shall, by order, assess administrative penalties. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice of, and the opportunity for, a hearing with regard to the person affected in accordance with Section 1397. The administrative penalties shall not be deemed an exclusive remedy available to the director. These penalties shall be paid to the Managed Care Administrative Fines and Penalties Fund and shall be used for the purposes specified in Section 1341.45.
(5)The department shall send a written notice of the final disposition of the grievance or external review decision, and the reasons therefor, to the subscriber or enrollee, the agent, to any provider that has joined with or is otherwise assisting the subscriber or enrollee, and to the plan, within 30 calendar days of receipt of the request for review unless the director, in his or her discretion, determines that additional time is reasonably necessary to fully and fairly evaluate the relevant grievance or external review decision. In any case not eligible for the independent medical review system established pursuant to Article 5.55 (commencing with Section 1374.30), the departments written notice shall include, at a minimum, the following:
(A)A summary of its findings and the reasons why the department found the plan to be, or not to be, in compliance with any applicable laws, regulations, or orders of the director.
(B)A discussion of the departments contact with any medical provider, or any other independent expert relied on by the department, along with a summary of the views and qualifications of that provider or expert.
(C)If the enrollees grievance or external review decision is sustained in whole or in part, information about any corrective action taken.
(6)In any department review of a grievance or external review decision involving a disputed health care service, as defined in subdivision (b) of Section 1374.30, that is not eligible for the independent medical review system established pursuant to Article 5.55 (commencing with Section 1374.30), in which the department finds that the plan has delayed, denied, or modified health care services that are medically necessary, based on the specific medical circumstances of the enrollee, and those services are a covered benefit under the terms and conditions of the health care service plan contract, the departments written notice shall do either of the following:
(A)Order the plan to promptly offer and provide those health care services to the enrollee.
(B)Order the plan to promptly reimburse the enrollee for any reasonable costs associated with urgent care or emergency services, or other extraordinary and compelling health care services, when the department finds that the enrollees decision to secure those services outside of the plan network was reasonable under the circumstances.
The departments order shall be binding on the plan.
(7)Distribution of the written notice shall not be deemed a waiver of any exemption or privilege under existing law, including, but not limited to, Section 6254.5 of the Government Code, for any information in connection with and including the written notice, nor shall any person employed or in any way retained by the department be required to testify as to that information or notice.
(8)The director shall establish and maintain a system of aging of grievances that are pending and unresolved for 30 days or more that shall include a brief explanation of the reasons each grievance is pending and unresolved for 30 days or more.
(9)A subscriber or enrollee, or the agent acting on behalf of a subscriber or enrollee, may also request voluntary mediation with the plan prior to exercising the right to submit a grievance or external review decision to the department. The use of mediation services shall not preclude the right to submit a grievance or external review decision to the department upon completion of mediation. In order to initiate mediation, the subscriber or enrollee, or the agent acting on behalf of the subscriber or enrollee, and the plan shall voluntarily agree to mediation. Expenses for mediation shall be borne equally by both sides. The department shall have no administrative or enforcement responsibilities in connection with the voluntary mediation process authorized by this paragraph.
(c)The plans grievance system shall include a system of aging of grievances that are pending and unresolved for 30 days or more. The plan shall provide a quarterly report to the director of grievances pending and unresolved for 30 or more days with separate categories of grievances for Medicare enrollees and Medi-Cal enrollees. The plan shall include with the report a brief explanation of the reasons each grievance is pending and unresolved for 30 days or more. The plan may include the following statement in the quarterly report that is made available to the public by the director:
Under Medicare and Medi-Cal law, Medicare enrollees and Medi-Cal enrollees each have separate avenues of appeal that are not available to other enrollees. Therefore, grievances pending and unresolved may reflect enrollees pursuing their Medicare or Medi-Cal appeal rights.
If requested by a plan, the director shall include this statement in a written report made available to the public and prepared by the director that describes or compares grievances that are pending and unresolved with the plan for 30 days or more. Additionally, the director shall, if requested by a plan, append to that written report a brief explanation, provided in writing by the plan, of the reasons why grievances described in that written report are pending and unresolved for 30 days or more. The director shall not be required to include a statement or append a brief explanation to a written report that the director is required to prepare under this chapter, including Sections 1380 and 1397.5.
(d)Subject to subparagraph (C) of paragraph (1) of subdivision (b), the grievance or resolution procedures authorized by this section shall be in addition to any other procedures that may be available to any person, and failure to pursue, exhaust, or engage in the procedures described in this section shall not preclude the use of any other remedy provided by law.
(e)Nothing in this section shall be construed to allow the submission to the department of any provider grievance under this section. However, as part of a providers duty to advocate for medically appropriate health care for his or her patients pursuant to Sections 510 and 2056 of the Business and Professions Code, nothing in this subdivision shall be construed to prohibit a provider from contacting and informing the department about any concerns he or she has regarding compliance with or enforcement of this chapter.
(f)To the extent required by Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations, there shall be an independent external review pursuant to the standards required by the United States Secretary of Health and Human Services of a health care service plans cancellation, rescission, or nonrenewal of an enrollees or subscribers coverage.
SEC. 5.Section 1368.01 of the Health and Safety Code is amended to read:1368.01.(a) The grievance system shall require the plan to resolve grievances within 30 days.
(b) The grievance system shall include a requirement for expedited plan review of grievances for cases involving an imminent and serious threat to the health of the patient, including, but not limited to, severe pain, potential loss of life, limb, or major bodily function. When the plan has notice of a case requiring expedited review, the grievance system shall require the plan to immediately inform enrollees and subscribers in writing of their right to notify the department of the grievance. The grievance system shall also require the plan to provide enrollees, subscribers, and the department with a written statement on the disposition or pending status of the grievance no later than three days from receipt of the grievance. Paragraph (4) of subdivision (a) of Section 1368 shall not apply to grievances handled pursuant to this section.
SEC. 6.Section 1374.30 of the Health and Safety Code is amended to read:1374.30.(a)Commencing January 1, 2001, there is hereby established in the department the Independent Medical Review System.
(b)For the purposes of this chapter, disputed health care service means any health care service eligible for coverage and payment under a health care service plan contract that has been denied, modified, or delayed by a decision of the plan, or by one of its contracting providers, in whole or in part due to a finding that the service is not medically necessary. A decision regarding a disputed health care service relates to the practice of medicine and is not a coverage decision. A disputed health care service does not include services provided by a specialized health care service plan, except to the extent that the service (1) involves the practice of medicine, or (2) is provided pursuant to a contract with a health care service plan that covers hospital, medical, or surgical benefits. If a plan, or one of its contracting providers, issues a decision denying, modifying, or delaying health care services, based in whole or in part on a finding that the proposed health care services are not a covered benefit under the contract that applies to the enrollee, the statement of decision shall clearly specify the provision in the contract that excludes that coverage.
(c)For the purposes of this chapter, coverage decision means the approval or denial of health care services by a plan, or by one of its contracting entities, substantially based on a finding that the provision of a particular service is included or excluded as a covered benefit under the terms and conditions of the health care service plan contract. A coverage decision does not encompass a plan or contracting provider decision regarding a disputed health care service.
(d)(1)All enrollee grievances involving a disputed health care service are eligible for review under the Independent Medical Review System if the requirements of this article are met. If the department finds that an enrollee grievance involving a disputed health care service does not meet the requirements of this article for review under the Independent Medical Review System, the enrollee request for review shall be treated as a request for the department to review the grievance pursuant to subdivision (b) of Section 1368. All other enrollee grievances, including grievances involving coverage decisions, remain eligible for review by the department pursuant to subdivision (b) of Section 1368.
(2)In any case in which an enrollee or provider asserts that a decision to deny, modify, or delay health care services was based, in whole or in part, on consideration of medical necessity, the department shall have the final authority to determine whether the grievance is more properly resolved pursuant to an independent medical review as provided under this article or pursuant to subdivision (b) of Section 1368.
(3)The department shall be the final arbiter when there is a question as to whether an enrollee grievance is a disputed health care service or a coverage decision. The department shall establish a process to complete an initial screening of an enrollee grievance. If there appears to be any medical necessity issue, the grievance shall be resolved pursuant to an independent medical review as provided under this article or pursuant to subdivision (b) of Section 1368.
(e)Every health care service plan contract that is issued, amended, renewed, or delivered in this state on or after January 1, 2000, shall provide an enrollee with the opportunity to seek an independent medical review whenever health care services have been denied, modified, or delayed by the plan, or by one of its contracting providers, if the decision was based in whole or in part on a finding that the proposed health care services are not medically necessary. For purposes of this article, an enrollee may designate an agent to act on his or her behalf, as described in paragraph (2) of subdivision (b) of Section 1368. The provider may join with or otherwise assist the enrollee in seeking an independent medical review, and may advocate on behalf of the enrollee.
(f)Medi-Cal beneficiaries enrolled in a health care service plan shall not be excluded from participation. Medicare beneficiaries enrolled in a health care service plan shall not be excluded unless expressly preempted by federal law. Reviews of cases for Medi-Cal enrollees shall be conducted in accordance with statutes and regulations for the Medi-Cal program.
(g)The department may seek to integrate the quality of care and consumer protection provisions, including remedies, of the Independent Medical Review System with related dispute resolution procedures of other health care agency programs, including the Medicare and Medi-Cal programs, in a way that minimizes the potential for duplication, conflict, and added costs. Nothing in this subdivision shall be construed to limit any rights conferred upon enrollees under this chapter.
(h)The independent medical review process authorized by this article is in addition to any other procedures or remedies that may be available.
(i)Every health care service plan shall prominently display in every plan member handbook or relevant informational brochure, in every plan contract, on enrollee evidence of coverage forms, on copies of plan procedures for resolving grievances, on letters of denials issued by either the plan or its contracting organization, on the grievance forms required under Section 1368, and on all written responses to grievances, information concerning the right of an enrollee to request an independent medical review in cases where the enrollee believes that health care services have been improperly denied, modified, or delayed by the plan, or by one of its contracting providers.
(j)An enrollee may apply to the department for an independent medical review when all of the following conditions are met:
(1)(A)The enrollees provider has recommended a health care service as medically necessary, or
(B)The enrollee has received urgent care or emergency services that a provider determined was medically necessary, or
(C)The enrollee, in the absence of a provider recommendation under subparagraph (A) or the receipt of urgent care or emergency services by a provider under subparagraph (B), has been seen by an in-plan provider for the diagnosis or treatment of the medical condition for which the enrollee seeks independent review. The plan shall expedite access to an in-plan provider upon request of an enrollee. The in-plan provider need not recommend the disputed health care service as a condition for the enrollee to be eligible for an independent review.
For purposes of this article, the enrollees provider may be an out-of-plan provider. However, the plan shall have no liability for payment of services provided by an out-of-plan provider, except as provided pursuant to subdivision (c) of Section 1374.34.
(2)The disputed health care service has been denied, modified, or delayed by the plan, or by one of its contracting providers, based in whole or in part on a decision that the health care service is not medically necessary.
(3)(A)The enrollee has filed a grievance with the plan or its contracting provider pursuant to Section 1368, and the disputed decision is upheld or the grievance remains unresolved after 30 days. The enrollee shall not be required to participate in the plans grievance process for more than 30 days. In the case of a grievance that requires expedited review pursuant to Section 1368.01, the enrollee shall not be required to participate in the plans grievance process for more than three days, or
(B)The enrollee has filed for an external review decision with the plan or its contracting provider pursuant to subdivision (b) of Section 1367.24, and the disputed decision is upheld or the external review remains unresolved after 72 hours, or 24 hours if exigent circumstances exist.
(k)An enrollee may apply to the department for an independent medical review of a decision to deny, modify, or delay health care services, based in whole or in part on a finding that the disputed health care services are not medically necessary, within six months of any of the qualifying periods or events under subdivision (j). The director may extend the application deadline beyond six months if the circumstances of a case warrant the extension.
(l)The enrollee shall pay no application or processing fees of any kind.
(m)As part of its notification to the enrollee regarding a disposition of the enrollees grievance that denies, modifies, or delays health care services, the plan shall provide the enrollee with a one- or two-page application form approved by the department, and an addressed envelope, which the enrollee may return to initiate an independent medical review. The plan shall include on the form any information required by the department to facilitate the completion of the independent medical review, such as the enrollees diagnosis or condition, the nature of the disputed health care service sought by the enrollee, a means to identify the enrollees case, and any other material information. The form shall also include the following:
(1)Notice that a decision not to participate in the independent medical review process may cause the enrollee to forfeit any statutory right to pursue legal action against the plan regarding the disputed health care service.
(2)A statement indicating the enrollees consent to obtain any necessary medical records from the plan, any of its contracting providers, and any out-of-plan provider the enrollee may have consulted on the matter, to be signed by the enrollee.
(3)Notice of the enrollees right to provide information or documentation, either directly or through the enrollees provider, regarding any of the following:
(A)A provider recommendation indicating that the disputed health care service is medically necessary for the enrollees medical condition.
(B)Medical information or justification that a disputed health care service, on an urgent care or emergency basis, was medically necessary for the enrollees medical condition.
(C)Reasonable information supporting the enrollees position that the disputed health care service is or was medically necessary for the enrollees medical condition, including all information provided to the enrollee by the plan or any of its contracting providers, still in the possession of the enrollee, concerning a plan or provider decision regarding disputed health care services, and a copy of any materials the enrollee submitted to the plan, still in the possession of the enrollee, in support of the grievance, as well as any additional material that the enrollee believes is relevant.
(4)A section designed to collect information on the enrollees ethnicity, race, and primary language spoken that includes both of the following:
(A)A statement of intent indicating that the information is used for statistics only, in order to ensure that all enrollees get the best care possible.
(B)A statement indicating that providing this information is optional and will not affect the independent medical review process in any way.
(n)Upon notice from the department that the health care service plans enrollee has applied for an independent medical review, the plan or its contracting providers shall provide to the independent medical review organization designated by the department a copy of all of the following documents within three business days of the plans receipt of the departments notice of a request by an enrollee for an independent review:
(1)(A)A copy of all of the enrollees medical records in the possession of the plan or its contracting providers relevant to each of the following:
(i)The enrollees medical condition.
(ii)The health care services being provided by the plan and its contracting providers for the condition.
(iii)The disputed health care services requested by the enrollee for the condition.
(B)Any newly developed or discovered relevant medical records in the possession of the plan or its contracting providers after the initial documents are provided to the independent medical review organization shall be forwarded immediately to the independent medical review organization. The plan shall concurrently provide a copy of medical records required by this subparagraph to the enrollee or the enrollees provider, if authorized by the enrollee, unless the offer of medical records is declined or otherwise prohibited by law. The confidentiality of all medical record information shall be maintained pursuant to applicable state and federal laws.
(2)A copy of all information provided to the enrollee by the plan and any of its contracting providers concerning plan and provider decisions regarding the enrollees condition and care, and a copy of any materials the enrollee or the enrollees provider submitted to the plan and to the plans contracting providers in support of the enrollees request for disputed health care services. This documentation shall include the written response to the enrollees grievance, required by paragraph (4) of subdivision (a) of Section 1368. The confidentiality of any enrollee medical information shall be maintained pursuant to applicable state and federal laws.
(3)A copy of any other relevant documents or information used by the plan or its contracting providers in determining whether disputed health care services should have been provided, and any statements by the plan and its contracting providers explaining the reasons for the decision to deny, modify, or delay disputed health care services on the basis of medical necessity. The plan shall concurrently provide a copy of documents required by this paragraph, except for any information found by the director to be legally privileged information, to the enrollee and the enrollees provider. The department and the independent medical review organization shall maintain the confidentiality of any information found by the director to be the proprietary information of the plan.
SEC. 7.Section 10123.190 is added to the Insurance Code, immediately following Section 10123.19, to read:10123.190.(a)(1)Every health insurer that provides prescription drug benefits shall maintain an expeditious process, as described in this subdivision, by which insureds, insureds designees, or prescribing providers may request and obtain authorization for medically necessary nonformulary prescription drugs and medically necessary formulary drugs that require prior authorization by the health insurer. The health insurer shall provide that the insured, the insureds designee, or the insureds prescribing provider may seek a prior authorization for a prescription drug under this subdivision.
(2)Each health insurer shall respond to a prior authorization request within 72 hours following receipt of the prior authorization request. A health insurer that grants a prior authorization request under this paragraph shall provide coverage of the prescription drug for the duration of the prescription, including refills.
(3)Each health insurer shall provide that a prior authorization may be obtained within 24 hours if an insured is suffering from a health condition that may seriously jeopardize the insureds life, health, or ability to regain maximum function or if an insured is undergoing a current course of treatment using a nonformulary drug. A health insurer that grants a prior authorization request under this paragraph based on exigent circumstances shall provide coverage of the prescription drug for the duration of the exigency.
(4)If a health insurer fails to respond within 72 hours for a prior authorization request, or within 24 hours if exigent circumstances exist, upon receipt of a completed prior authorization request, the prior authorization request shall be deemed to have been granted.
(5)Each health insurer shall provide a written description of the process described in paragraph (1) to its prescribing providers. For purposes of this section, a prescribing provider shall include a provider authorized to write a prescription, pursuant to subdivision (a) of Section 4040 of the Business and Professions Code, to treat a medical condition of an insured.
(b)If a health insurer disapproves a prior authorization request made pursuant to subdivision (a), the health insurer shall maintain an expeditious process to authorize an insured to obtain an external review.
(1)A determination on an external review shall be made no later than 72 hours following receipt of the request, if the original request was an authorization request under paragraph (2) of subdivision (a), and no later than 24 hours following receipt of the request, if the original request was an authorization request under paragraph (3) of subdivision (a).
(2)If an external review decision of a prior authorization request under paragraph (2) of subdivision (a) is granted, the health insurer shall provide coverage of the prescription drug for the duration of the prescription, including refills. If an external review decision of a prior authorization request under paragraph (3) of subdivision (a) is granted, the health insurer shall provide coverage of the prescription drug for the duration of the exigency.
(c)Any health insurer that disapproves a request made pursuant to subdivision (a) to obtain authorization for a nonformulary or formulary drug shall provide the reasons for the disapproval in a notice provided to the insured. The notice shall indicate that the insured may file, in lieu of filing a grievance with the health insurer, a request for an external review pursuant to subdivision (b) if the insured objects to the disapproval, including any alternative drug or treatment offered by the health insurer. If a health insurer disapproves a request made pursuant to subdivision (a), an insured shall not be required to file a grievance with the health insurer or its contracting provider pursuant the grievance process established by the health insurer.
(d)The process described in subdivisions (a) and (b) by which insureds may obtain medically necessary nonformulary and formulary drugs shall be described in the evidence of coverage or certificate of insurance issued by the health insurer on or after July 1, 2017.
(e)A health insurance policy in the individual, small group, and large group markets that provides coverage for outpatient prescription drugs shall comply with this section.
(f)Nothing in this section shall be construed to affect an insureds or policyholders eligibility to submit a complaint to the department for review or to apply to the department for an independent medical review under Article 3.5 (commencing with Section 10169).
SEC. 8.Section 10123.191 of the Insurance Code is amended to read:10123.191.(a)Notwithstanding any other law, on and after January 1, 2013, a health insurer that provides coverage for prescription drugs shall utilize and accept only the prior authorization form developed pursuant to subdivision (b), or an electronic prior authorization process described in subdivision (d), when requiring prior authorization for prescription drugs.
(b)On or before January 1, 2017, the department and the Department of Managed Health Care shall jointly develop a uniform prior authorization form. Notwithstanding any other law, on and after July 1, 2017, or six months after the form is completed pursuant to this section, whichever is later, every prescribing provider shall use that uniform prior authorization form, or an electronic prior authorization process described in subdivision (d), to request prior authorization for coverage of prescription drugs and every health insurer shall accept that form or electronic process as sufficient to request prior authorization for prescription drugs.
(c)The prior authorization form developed pursuant to subdivision (b) shall meet the following criteria:
(1)The form shall not exceed two pages.
(2)The form shall be made electronically available by the department and the health insurer.
(3)The completed form may also be electronically submitted from the prescribing provider to the health insurer.
(4)The department and the Department of Managed Health Care shall develop the form with input from interested parties from at least one public meeting.
(5)The department and the Department of Managed Health Care, in development of the standardized form, shall take into consideration the following:
(A)Existing prior authorization forms established by the federal Centers for Medicare and Medicaid Services and the State Department of Health Care Services.
(B)National standards pertaining to electronic prior authorization.
(d)A prescribing provider may use an electronic prior authorization system utilizing the standardized form described in subdivision (b) or an electronic process developed specifically for transmitting prior authorization information that meets the National Council for Prescription Drug Programs SCRIPT standard for electronic prior authorization transactions.
(e)Subdivision (a) does not apply if any of the following occurs:
(1)A contracted physician group is delegated the financial risk for the pharmacy or medical drug benefit by a health insurer.
(2)A contracted physician group uses its own internal prior authorization process rather than the health insurers prior authorization process for the health insurers insureds.
(3)A contracted physician group is delegated a utilization management function by the health insurer concerning any prescription drug, regardless of the delegation of financial risk.
(f)For prescription drugs, prior authorization requirements described in subdivisions (b) and (d) apply regardless of how that benefit is classified under the terms of the health insurers group or individual policy.
(g)For purposes of this section:
(1)Prescribing provider shall include a provider authorized to write a prescription, pursuant to subdivision (a) of Section 4040 of the Business and Professions Code, to treat a medical condition of an insured.
(2)Completed prior authorization request means a completed uniform prior authorization form developed pursuant to subdivision (b), or a completed request submitted using an electronic prior authorization system described in subdivision (d), or, for contracted physician groups described in subdivision (e), the process used by the contracted physician group.
SEC. 9.Section 10123.197 of the Insurance Code is amended to read:10123.197.(a)A request for an exception to a health insurers step therapy process for prescription drugs may be submitted in the same manner as a request for prior authorization for prescription drugs pursuant to Section 10123.190 and shall be treated in the same manner, and shall be responded to by the health insurer in the same manner, as a request for prior authorization for prescription drugs.
(b)The department and the Department of Managed Health Care shall include a provision for step therapy exception requests in the uniform prior authorization form developed pursuant to subdivision (b) of Section 10123.191.
SEC. 10.Section 10169 of the Insurance Code, as added by Section 19 of Chapter 348 of the Statutes of 2015, is amended to read:10169.(a)Commencing January 1, 2001, there is hereby established in the department the Independent Medical Review System.
(b)For the purposes of this chapter, disputed health care service means any health care service eligible for coverage and payment under a disability insurance contract that has been denied, modified, or delayed by a decision of the insurer, or by one of its contracting providers, in whole or in part due to a finding that the service is not medically necessary. A decision regarding a disputed health care service relates to the practice of medicine and is not a coverage decision. A disputed health care service does not include services provided by a group or individual policy of vision-only or dental-only coverage, except to the extent that (1) the service involves the practice of medicine, or (2) is provided pursuant to a contract with a disability insurer that covers hospital, medical, or surgical benefits. If an insurer, or one of its contracting providers, issues a decision denying, modifying, or delaying health care services, based in whole or in part on a finding that the proposed health care services are not a covered benefit under the contract that applies to the insured, the statement of decision shall clearly specify the provision in the contract that excludes that coverage.
(c)For the purposes of this chapter, coverage decision means the approval or denial of health care services by a disability insurer, or by one of its contracting entities, substantially based on a finding that the provision of a particular service is included or excluded as a covered benefit under the terms and conditions of the disability insurance contract. A coverage decision does not encompass a disability insurer or contracting provider decision regarding a disputed health care service.
(d)(1)All insured grievances involving a disputed health care service are eligible for review under the Independent Medical Review System if the requirements of this article are met. If the department finds that an insured grievance involving a disputed health care service does not meet the requirements of this article for review under the Independent Medical Review System, the insured request for review shall be treated as a request for the department to review the grievance. All other insured grievances, including grievances involving coverage decisions, remain eligible for review by the department.
(2)In any case in which an insured or provider asserts that a decision to deny, modify, or delay health care services was based, in whole or in part, on consideration of medical necessity, the department shall have the final authority to determine whether the grievance is more properly resolved pursuant to an independent medical review as provided under this article.
(3)The department shall be the final arbiter when there is a question as to whether an insured grievance is a disputed health care service or a coverage decision. The department shall establish a process to complete an initial screening of an insured grievance. If there appears to be any medical necessity issue, the grievance shall be resolved pursuant to an independent medical review as provided under this article.
(e)Every disability insurance contract that is issued, amended, renewed, or delivered in this state on or after January 1, 2000, shall provide an insured with the opportunity to seek an independent medical review whenever health care services have been denied, modified, or delayed by the insurer, or by one of its contracting providers, if the decision was based in whole or in part on a finding that the proposed health care services are not medically necessary. For purposes of this article, an insured may designate an agent to act on his or her behalf. The provider may join with or otherwise assist the insured in seeking an independent medical review, and may advocate on behalf of the insured.
(f)Medicare beneficiaries enrolled in Medicare + Choice products shall not be excluded unless expressly preempted by federal law.
(g)The department may seek to integrate the quality of care and consumer protection provisions, including remedies, of the Independent Medical Review System with related dispute resolution procedures of other health care agency programs, including the Medicare program, in a way that minimizes the potential for duplication, conflict, and added costs. Nothing in this subdivision shall be construed to limit any rights conferred upon insureds under this chapter.
(h)The independent medical review process authorized by this article is in addition to any other procedures or remedies that may be available.
(i)Every disability insurer shall prominently display in every insurer member handbook or relevant informational brochure, in every insurance contract, on insured evidence of coverage forms, on copies of insurer procedures for resolving grievances, on letters of denials issued by either the insurer or its contracting organization, and on all written responses to grievances, information concerning the right of an insured to request an independent medical review when the insured believes that health care services have been improperly denied, modified, or delayed by the insurer, or by one of its contracting providers. The departments telephone number, 1-800-927-4357, and Internet Web site, www.insurance.ca.gov, shall also be displayed.
(j)An insured may apply to the department for an independent medical review when all of the following conditions are met:
(1)(A)The insureds provider has recommended a health care service as medically necessary, or
(B)The insured has received urgent care or emergency services that a provider determined was medically necessary, or
(C)The insured, in the absence of a provider recommendation under subparagraph (A) or the receipt of urgent care or emergency services by a provider under subparagraph (B), has been seen by a contracting provider for the diagnosis or treatment of the medical condition for which the insured seeks independent review. The insurer shall expedite access to a contracting provider upon request of an insured. The contracting provider need not recommend the disputed health care service as a condition for the insured to be eligible for an independent review.
For purposes of this article, the insureds provider may be a noncontracting provider. However, the insurer shall have no liability for payment of services provided by a noncontracting provider, except as provided pursuant to Section 10169.3.
(2)The disputed health care service has been denied, modified, or delayed by the insurer, or by one of its contracting providers, based in whole or in part on a decision that the health care service is not medically necessary.
(3)(A)The insured has filed a grievance with the insurer or its contracting provider, and the disputed decision is upheld or the grievance remains unresolved after 30 days. The insured shall not be required to participate in the insurers grievance process for more than 30 days. In the case of a grievance that requires expedited review, the insured shall not be required to participate in the insurers grievance process for more than three days, or
(B)The insured has filed for an external review decision with the insurer or its contracting provider pursuant to subdivision (b) of Section 10123.190, and the disputed decision is upheld or the external review remains unresolved after 72 hours, or 24 hours if exigent circumstances exist.
(k)An insured may apply to the department for an independent medical review of a decision to deny, modify, or delay health care services, based in whole or in part on a finding that the disputed health care services are not medically necessary, within six months of any of the qualifying periods or events under subdivision (j). The commissioner may extend the application deadline beyond six months if the circumstances of a case warrant the extension.
(l)The insured shall pay no application or processing fees of any kind.
(m)As part of its notification to the insured regarding a disposition of the insureds grievance that denies, modifies, or delays health care services, the insurer shall provide the insured with a one- or two-page application form approved by the department, and an addressed envelope, which the insured may return to initiate an independent medical review. The insurer shall include on the form any information required by the department to facilitate the completion of the independent medical review, such as the insureds diagnosis or condition, the nature of the disputed health care service sought by the insured, a means to identify the insureds case, and any other material information. The form shall also include the following:
(1)Notice that a decision not to participate in the independent review process may cause the insured to forfeit any statutory right to pursue legal action against the insurer regarding the disputed health care service.
(2)A statement indicating the insureds consent to obtain any necessary medical records from the insurer, any of its contracting providers, and any noncontracting provider the insured may have consulted on the matter, to be signed by the insured.
(3)Notice of the insureds right to provide information or documentation, either directly or through the insureds provider, regarding any of the following:
(A)A provider recommendation indicating that the disputed health care service is medically necessary for the insureds medical condition.
(B)Medical information or justification that a disputed health care service, on an urgent care or emergency basis, was medically necessary for the insureds medical condition.
(C)Reasonable information supporting the insureds position that the disputed health care service is or was medically necessary for the insureds medical condition, including all information provided to the insured by the insurer or any of its contracting providers, still in the possession of the insured, concerning an insurer or provider decision regarding disputed health care services, and a copy of any materials the insured submitted to the insurer, still in the possession of the insured, in support of the grievance, as well as any additional material that the insured believes is relevant.
(4)A section designed to collect information on the insureds ethnicity, race, and primary language spoken that includes both of the following:
(A)A statement of intent indicating that the information is used for statistics only, in order to ensure that all insureds get the best care possible.
(B)A statement indicating that providing this information is optional and will not affect the independent medical review process in any way.
(n)Upon notice from the department that the insured has applied for an independent medical review, the insurer or its contracting providers, shall provide to the independent medical review organization designated by the department a copy of all of the following documents within three business days of the insurers receipt of the departments notice of a request by an insured for an independent review:
(1)(A)A copy of all of the insureds medical records in the possession of the insurer or its contracting providers relevant to each of the following:
(i)The insureds medical condition.
(ii)The health care services being provided by the insurer and its contracting providers for the condition.
(iii)The disputed health care services requested by the insured for the condition.
(B)Any newly developed or discovered relevant medical records in the possession of the insurer or its contracting providers after the initial documents are provided to the independent medical review organization shall be forwarded immediately to the independent medical review organization. The insurer shall concurrently provide a copy of medical records required by this subparagraph to the insured or the insureds provider, if authorized by the insured, unless the offer of medical records is declined or otherwise prohibited by law. The confidentiality of all medical record information shall be maintained pursuant to applicable state and federal laws.
(2)A copy of all information provided to the insured by the insurer and any of its contracting providers concerning insurer and provider decisions regarding the insureds condition and care, and a copy of any materials the insured or the insureds provider submitted to the insurer and to the insurers contracting providers in support of the insureds request for disputed health care services. This documentation shall include the written response to the insureds grievance. The confidentiality of any insured medical information shall be maintained pursuant to applicable state and federal laws.
(3)A copy of any other relevant documents or information used by the insurer or its contracting providers in determining whether disputed health care services should have been provided, and any statements by the insurer and its contracting providers explaining the reasons for the decision to deny, modify, or delay disputed health care services on the basis of medical necessity. The insurer shall concurrently provide a copy of documents required by this paragraph, except for any information found by the commissioner to be legally privileged information, to the insured and the insureds provider. The department and the independent medical review organization shall maintain the confidentiality of any information found by the commissioner to be the proprietary information of the insurer.
SEC. 11.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)(1)Every health care service plan that provides prescription drug benefits shall maintain an expeditious process, as described in this subdivision, by which enrollees, enrollees designees, or prescribing providers may request and obtain authorization for a medically necessary nonformulary prescription drug. On or before July 1, 1999, every health care service plan that provides prescription drug benefits shall file with the department a description of its process, including timelines, for responding to authorization requests for nonformulary drugs. Any changes to this process shall be filed with the department pursuant to Section 1352. Each drugs and medically necessary formulary prescription drugs that require prior authorization by the plan. The plan shall provide that the enrollee, the enrollees designee, or the enrollees prescribing provider may seek a prior authorization for a prescription drug under this subdivision.
(2)Each plan shall respond to a prior authorization request within 72 hours following receipt of the prior authorization request. A plan that grants a prior authorization request under this paragraph shall provide coverage of the prescription drug for the duration of the prescription, including refills.
(3)Each plan shall provide that a prior authorization may be obtained within 24 hours if an enrollee is suffering from a health condition that may seriously jeopardize the enrollees life, health, or ability to regain maximum function or if an enrollee is undergoing a current course of treatment using a nonformulary drug. A plan that grants a prior authorization request under this paragraph based on exigent circumstances shall provide coverage of the prescription drug for the duration of the exigency.
(4)If a plan fails to respond within 72 hours for a prior authorization request, or within 24 hours if exigent circumstances exist, upon receipt of a completed prior authorization request, the prior authorization request shall be deemed to have been granted.
(5)Each plan shall provide a written description of its most current process, including timelines, the process described in paragraph (1) to its prescribing providers. For purposes of this section, a prescribing provider shall include a provider authorized to write a prescription, pursuant to subdivision (a) of Section 4040 of the Business and Professions Code, to treat a medical condition of an enrollee.
(b)If a plan disapproves a prior authorization request made pursuant to subdivision (a), the plan shall maintain an expeditious process to authorize an enrollee to obtain an external review.
(1)A determination on an external review shall be made no later than 72 hours following receipt of the request, if the original request was an authorization request under paragraph (2) of subdivision (a), and no later than 24 hours following receipt of the request, if the original request was an authorization request under paragraph (3) of subdivision (a).
(2)If an external review decision of a prior authorization request under paragraph (2) of subdivision (a) is granted, the plan shall provide coverage of the prescription drug for the duration of the prescription, including refills. If an external review decision of a prior authorization request under paragraph (3) of subdivision (a) is granted, the plan shall provide coverage of the prescription drug for the duration of the exigency.
(b)
(c)Any plan that disapproves a request made pursuant to subdivision (a) by a prescribing provider to obtain authorization for a nonformulary or formulary drug shall provide the reasons for the disapproval in a notice provided to the enrollee. The notice shall indicate that the enrollee may file a grievance with the plan file, in lieu of filing a grievance with the plan, a request for an external review pursuant to subdivision (b) if the enrollee objects to the disapproval, including any alternative drug or treatment offered by the plan. The notice shall comply with subdivision (b) of Section 1368.02. Any health plan that is required to maintain an external exception request review process pursuant to subdivision (k) shall indicate in the notice required under this subdivision that the enrollee may file a grievance seeking an external exception request review. If a plan disapproves a request made pursuant to subdivision (a), an enrollee shall not be required to file a grievance with the plan or its contracting provider pursuant to Section 1368.
(c)
(d)The process described in subdivision subdivisions (a) and (b) by which enrollees, enrollees designees, and prescribing providers may obtain authorization for medically necessary nonformulary drugs shall not apply to a nonformulary drug that has been prescribed for an enrollee in conformance with the provisions of Section 1367.22.
(d)
(e)The process described in subdivision subdivisions (a) and (b) by which enrollees may obtain medically necessary nonformulary drugs, including specified timelines for responding to prescribing provider authorization requests, drugs and formulary drugs shall be described in evidence of coverage and disclosure forms, as required by subdivision (a) of Section 1363, issued on or after July 1, 1999. July 1, 2017.
(e)
(f)Every health care service plan that provides prescription drug benefits shall maintain, as part of its books and records under Section 1381, all of the following information, which shall be made available to the director upon request:
(1)The complete drug formulary or formularies of the plan, if the plan maintains a formulary, including a list of the prescription drugs on the formulary of the plan by major therapeutic category with an indication of whether any drugs are preferred over other drugs.
(2)Records developed by the pharmacy and therapeutic committee of the plan, or by others responsible for developing, modifying, and overseeing formularies, including medical groups, individual practice associations, and contracting pharmaceutical benefit management companies, used to guide the drugs prescribed for the enrollees of the plan, that fully describe the reasoning behind formulary decisions.
(3)Any plan arrangements with prescribing providers, medical groups, individual practice associations, pharmacists, contracting pharmaceutical benefit management companies, or other entities that are associated with activities of the plan to encourage formulary compliance or otherwise manage prescription drug benefits.
(f)
(g)If a plan provides prescription drug benefits, the department shall, as part of its periodic onsite medical survey of each plan undertaken pursuant to Section 1380, review the performance of the plan in providing those benefits, including, but not limited to, a review of the procedures and information maintained pursuant to this section, and describe the performance of the plan as part of its report issued pursuant to Section 1380.
(g)
(h)The director shall not publicly disclose any information reviewed pursuant to this section that is determined by the director to be confidential pursuant to state law.
(h)
(i)For purposes of this section, authorization means approval by the health care service plan to provide payment for the prescription drug.
(i)
(j)Nonformulary prescription drugs shall include any drug for which an enrollees copayment or out-of-pocket costs are different than the copayment for a formulary prescription drug, except as otherwise provided by law or regulation or in cases in which the drug has been excluded in the plan contract pursuant to Section 1342.7.
(j)
(k)Nothing in this section shall be construed to restrict or impair the application of any other provision of this chapter, including, but not limited to, Section 1367, which includes among its requirements that a health care service plan furnish services in a manner providing continuity of care and demonstrate that medical decisions are rendered by qualified medical providers unhindered by fiscal and administrative management.
(k)For any individual, small group, or large health plan contracts, a health care service plans process described in subdivision (a) shall comply with the request for exception and external exception request review processes described in subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations. This subdivision shall not apply to Medi-Cal managed care health care service plan contracts as described in subdivision (l).
(l)A health care service plan contract in the individual, small group, and large group markets that provides coverage for outpatient prescription drugs shall comply with this section. This section shall not apply to Medi-Cal managed care health care service plan contracts.
(l)
(m)Medi-Cal managed care health care service plan contract means any entity that enters into a contract with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000), Chapter 8 (commencing with Section 14200), or Chapter 8.75 (commencing with Section 14591) of Part 3 of Division 9 of the Welfare and Institutions Code.
(m)
(n)Nothing in this section shall be construed to affect an enrollees or subscribers eligibility to submit a grievance to the department for review under Section 1368 or to apply to the department for an independent medical review under Section 1370.4, or Article 5.55 (commencing with Section 1374.30) of this chapter.
SEC. 2.Section 1367.241 of the Health and Safety Code is amended to read:1367.241.(a)Notwithstanding any other law, on and after January 1, 2013, a health care service plan that provides coverage for prescription drugs shall accept only the prior authorization form developed pursuant to subdivision (c), (b), or an electronic prior authorization process described in subdivision (e), (d), when requiring prior authorization for prescription drugs. This section does not apply in the event that a physician or physician group has been delegated the financial risk for prescription drugs by a health care service plan and does not use a prior authorization process. This section does not apply to a health care service plan, or to its affiliated providers, if the health care service plan owns and operates its pharmacies and does not use a prior authorization process for prescription drugs.
(b)If a health care service plan or a contracted physician group fails to respond within 72 hours for nonurgent requests, and within 24 hours if exigent circumstances exist, upon receipt of a completed prior authorization request from a prescribing provider, the prior authorization request shall be deemed to have been granted. The requirements of this subdivision shall not apply to contracts entered into pursuant to Chapter 7 (commencing with Section 14000), Chapter 8 (commencing with Section 14200), or Chapter 8.75 (commencing with Section 14591) of Part 3 of Division 9 of the Welfare and Institutions Code. Medi-Cal managed care health care service plans that contract under those chapters shall not be required to maintain an external exception request review as provided in Section 156.122 of Title 45 of the Code of Federal Regulations.
(c)
(b)On or before January 1, 2017, the department and the Department of Insurance shall jointly develop a uniform prior authorization form. Notwithstanding any other law, on and after July 1, 2017, or six months after the form is completed pursuant to this section, whichever is later, every prescribing provider shall use that uniform prior authorization form, or an electronic prior authorization process described in subdivision (e), (d), to request prior authorization for coverage of prescription drugs and every health care service plan shall accept that form or electronic process as sufficient to request prior authorization for prescription drugs.
(d)
(c)The prior authorization form developed pursuant to subdivision (c) (b) shall meet the following criteria:
(1)The form shall not exceed two pages.
(2)The form shall be made electronically available by the department and the health care service plan.
(3)The completed form may also be electronically submitted from the prescribing provider to the health care service plan.
(4)The department and the Department of Insurance shall develop the form with input from interested parties from at least one public meeting.
(5)The department and the Department of Insurance, in development of the standardized form, shall take into consideration the following:
(A)Existing prior authorization forms established by the federal Centers for Medicare and Medicaid Services and the State Department of Health Care Services.
(B)National standards pertaining to electronic prior authorization.
(e)
(d)A prescribing provider may use an electronic prior authorization system utilizing the standardized form described in subdivision (c) (b) or an electronic process developed specifically for transmitting prior authorization information that meets the National Council for Prescription Drug Programs SCRIPT standard for electronic prior authorization transactions.
(f)
(e)Subdivision (a) does not apply if any of the following occurs:
(1)A contracted physician group is delegated the financial risk for prescription drugs by a health care service plan.
(2)A contracted physician group uses its own internal prior authorization process rather than the health care service plans prior authorization process for plan enrollees.
(3)A contracted physician group is delegated a utilization management function by the health care service plan concerning any prescription drug, regardless of the delegation of financial risk.
(g)
(f)For prescription drugs, prior authorization requirements described in subdivisions (c) (b) and (e) (d) apply regardless of how that benefit is classified under the terms of the health plans group or individual contract.
(h)
(g)For purposes of this section:
(1)Prescribing provider shall include a provider authorized to write a prescription, pursuant to subdivision (a) of Section 4040 of the Business and Professions Code, to treat a medical condition of an enrollee.
(2)Exigent circumstances exist when an enrollee is suffering from a health condition that may seriously jeopardize the enrollees life, health, or ability to regain maximum function or when an enrollee is undergoing a current course of treatment using a nonformulary drug.
(3)
(2)Completed prior authorization request means a completed uniform prior authorization form developed pursuant to subdivision (c), (b), or a completed request submitted using an electronic prior authorization system described in subdivision (e), (d), or, for contracted physician groups described in subdivision (f), (e), the process used by the contracted physician group.
SEC. 3.Section 1367.244 of the Health and Safety Code is amended to read:1367.244.(a)A request for an exception to a health care service plans step therapy process for prescription drugs may be submitted in the same manner as a request for prior authorization for prescription drugs pursuant to Section 1367.241, 1367.24, and shall be treated in the same manner, and shall be responded to by the health care service plan in the same manner, as a request for prior authorization for prescription drugs.
(b)The department and the Department of Insurance shall include a provision for step therapy exception requests in the uniform prior authorization form developed pursuant to subdivision (c) (b) of Section 1367.241.
SEC. 4.Section 1368 of the Health and Safety Code is amended to read:1368.(a)Every plan shall do all of the following:
(1)Establish and maintain a grievance system approved by the department under which enrollees may submit their grievances to the plan. Each system shall provide reasonable procedures in accordance with department regulations that shall ensure adequate consideration of enrollee grievances and rectification when appropriate.
(2)Inform its subscribers and enrollees upon enrollment in the plan and annually thereafter of the procedure for processing and resolving grievances. The information shall include the location and telephone number where grievances may be submitted.
(3)Provide forms for grievances to be given to subscribers and enrollees who wish to register written grievances. The forms used by plans licensed pursuant to Section 1353 shall be approved by the director in advance as to format.
(4)(A)Provide for a written acknowledgment within five calendar days of the receipt of a grievance, except as noted in subparagraph (B). The acknowledgment shall advise the complainant of the following:
(i)That the grievance has been received.
(ii)The date of receipt.
(iii)The name of the plan representative and the telephone number and address of the plan representative who may be contacted about the grievance.
(B)(i)Grievances received by telephone, by facsimile, by email, or online through the plans Internet Web site pursuant to Section 1368.015, that are not coverage disputes, disputed health care services involving medical necessity, or experimental or investigational treatment and that are resolved by the next business day following receipt are exempt from the requirements of subparagraph (A) and paragraph (5). The plan shall maintain a log of all these grievances. The log shall be periodically reviewed by the plan and shall include the following information for each complaint:
(I)
(i)The date of the call.
(II)
(ii)The name of the complainant.
(III)
(iii)The complainants member identification number.
(IV)
(iv)The nature of the grievance.
(V)
(v)The nature of the resolution.
(VI)
(vi)The name of the plan representative who took the call and resolved the grievance.
(ii)For health plan contracts in the individual, small group, or large group markets, a health care service plans response to grievances subject to Section 1367.24 shall also comply with subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations. This paragraph shall not apply to Medi-Cal managed care health care service plan contracts or any entity that enters into a contract with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000), Chapter 8 (commencing with Section 14200), or Chapter 8.75 (commencing with Section 14591) of Part 3 of Division 9 of the Welfare and Institutions Code.
(5)Provide subscribers and enrollees with written responses to grievances, with a clear and concise explanation of the reasons for the plans response. For grievances involving the delay, denial, or modification of health care services, the plan response shall describe the criteria used and the clinical reasons for its decision, including all criteria and clinical reasons related to medical necessity. If a plan, or one of its contracting providers, issues a decision delaying, denying, or modifying health care services based in whole or in part on a finding that the proposed health care services are not a covered benefit under the contract that applies to the enrollee, the decision shall clearly specify the provisions in the contract that exclude that coverage.
(6)For grievances involving the cancellation, rescission, or nonrenewal of a health care service plan contract, the health care service plan shall continue to provide coverage to the enrollee or subscriber under the terms of the health care service plan contract until a final determination of the enrollees or subscribers request for review has been made by the health care service plan or the director pursuant to Section 1365 and this section. This paragraph shall not apply if the health care service plan cancels or fails to renew the enrollees or subscribers health care service plan contract for nonpayment of premiums pursuant to paragraph (1) of subdivision (a) of Section 1365.
(7)Keep in its files all copies of grievances, and the responses thereto, for a period of five years.
(b)(1)(A)After either completing the grievance process described in subdivision (a), or (a), participating in the process for at least 30 days, or completing the external review process described in subdivision (b) of Section 1367.24, a subscriber or enrollee may submit the grievance or external review decision to the department for review. In any case under the grievance process determined by the department to be a case involving an imminent and serious threat to the health of the patient, including, but not limited to, severe pain, the potential loss of life, limb, or major bodily function, cancellations, rescissions, or the nonrenewal of a health care service plan contract, or in any other case where the department determines that an earlier review is warranted, a subscriber or enrollee shall not be required to complete the grievance process or to participate in the process for at least 30 days before submitting a grievance to the department for review.
(B)A grievance or external review decision may be submitted to the department for review and resolution prior to any arbitration.
(C)Notwithstanding subparagraphs (A) and (B), the department may refer any grievance or external review decision that does not pertain to compliance with this chapter to the State Department of Public Health, the California Department of Aging, the federal Health Care Financing Administration, Centers for Medicare and Medicaid Services, or any other appropriate governmental entity for investigation and resolution.
(2)If the subscriber or enrollee is a minor, or is incompetent or incapacitated, the parent, guardian, conservator, relative, or other designee of the subscriber or enrollee, as appropriate, may submit the grievance or external review decision to the department as the agent of the subscriber or enrollee. Further, a provider may join with, or otherwise assist, a subscriber or enrollee, or the agent, to submit the grievance or external review decision to the department. In addition, following submission of the grievance or external review decision to the department, the subscriber or enrollee, or the agent, may authorize the provider to assist, including advocating on behalf of the subscriber or enrollee. For purposes of this section, a relative includes the parent, stepparent, spouse, adult son or daughter, grandparent, brother, sister, uncle, or aunt of the subscriber or enrollee.
(3)The department shall review the written documents submitted with the subscribers or the enrollees request for review, or submitted by the agent on behalf of the subscriber or enrollee. The department may ask for additional information, and may hold an informal meeting with the involved parties, including providers who have joined in submitting the grievance or external review decision or who are otherwise assisting or advocating on behalf of the subscriber or enrollee. If after reviewing the record, the department concludes that the grievance, grievance or external review decision, in whole or in part, is eligible for review under the independent medical review system established pursuant to Article 5.55 (commencing with Section 1374.30), the department shall immediately notify the subscriber or enrollee, or agent, of that option and shall, if requested orally or in writing, assist the subscriber or enrollee in participating in the independent medical review system.
(4)If after reviewing the record of a grievance, grievance or external review decision, the department concludes that a health care service eligible for coverage and payment under a health care service plan contract has been delayed, denied, or modified by a plan, or by one of its contracting providers, in whole or in part due to a determination that the service is not medically necessary, and that determination was not communicated to the enrollee in writing along with a notice of the enrollees potential right to participate in the independent medical review system, as required by this chapter, the director shall, by order, assess administrative penalties. A proceeding for the issuance of an order assessing administrative penalties shall be subject to appropriate notice of, and the opportunity for, a hearing with regard to the person affected in accordance with Section 1397. The administrative penalties shall not be deemed an exclusive remedy available to the director. These penalties shall be paid to the Managed Care Administrative Fines and Penalties Fund and shall be used for the purposes specified in Section 1341.45.
(5)The department shall send a written notice of the final disposition of the grievance, grievance or external review decision, and the reasons therefor, to the subscriber or enrollee, the agent, to any provider that has joined with or is otherwise assisting the subscriber or enrollee, and to the plan, within 30 calendar days of receipt of the request for review unless the director, in his or her discretion, determines that additional time is reasonably necessary to fully and fairly evaluate the relevant grievance. grievance or external review decision. In any case not eligible for the independent medical review system established pursuant to Article 5.55 (commencing with Section 1374.30), the departments written notice shall include, at a minimum, the following:
(A)A summary of its findings and the reasons why the department found the plan to be, or not to be, in compliance with any applicable laws, regulations, or orders of the director.
(B)A discussion of the departments contact with any medical provider, or any other independent expert relied on by the department, along with a summary of the views and qualifications of that provider or expert.
(C)If the enrollees grievance or external review decision is sustained in whole or in part, information about any corrective action taken.
(6)In any department review of a grievance or external review decision involving a disputed health care service, as defined in subdivision (b) of Section 1374.30, that is not eligible for the independent medical review system established pursuant to Article 5.55 (commencing with Section 1374.30), in which the department finds that the plan has delayed, denied, or modified health care services that are medically necessary, based on the specific medical circumstances of the enrollee, and those services are a covered benefit under the terms and conditions of the health care service plan contract, the departments written notice shall do either of the following:
(A)Order the plan to promptly offer and provide those health care services to the enrollee.
(B)Order the plan to promptly reimburse the enrollee for any reasonable costs associated with urgent care or emergency services, or other extraordinary and compelling health care services, when the department finds that the enrollees decision to secure those services outside of the plan network was reasonable under the circumstances.
The departments order shall be binding on the plan.
(7)Distribution of the written notice shall not be deemed a waiver of any exemption or privilege under existing law, including, but not limited to, Section 6254.5 of the Government Code, for any information in connection with and including the written notice, nor shall any person employed or in any way retained by the department be required to testify as to that information or notice.
(8)The director shall establish and maintain a system of aging of grievances that are pending and unresolved for 30 days or more that shall include a brief explanation of the reasons each grievance is pending and unresolved for 30 days or more.
(9)A subscriber or enrollee, or the agent acting on behalf of a subscriber or enrollee, may also request voluntary mediation with the plan prior to exercising the right to submit a grievance or external review decision to the department. The use of mediation services shall not preclude the right to submit a grievance or external review decision to the department upon completion of mediation. In order to initiate mediation, the subscriber or enrollee, or the agent acting on behalf of the subscriber or enrollee, and the plan shall voluntarily agree to mediation. Expenses for mediation shall be borne equally by both sides. The department shall have no administrative or enforcement responsibilities in connection with the voluntary mediation process authorized by this paragraph.
(c)The plans grievance system shall include a system of aging of grievances that are pending and unresolved for 30 days or more. The plan shall provide a quarterly report to the director of grievances pending and unresolved for 30 or more days with separate categories of grievances for Medicare enrollees and Medi-Cal enrollees. The plan shall include with the report a brief explanation of the reasons each grievance is pending and unresolved for 30 days or more. The plan may include the following statement in the quarterly report that is made available to the public by the director:
Under Medicare and Medi-Cal law, Medicare enrollees and Medi-Cal enrollees each have separate avenues of appeal that are not available to other enrollees. Therefore, grievances pending and unresolved may reflect enrollees pursuing their Medicare or Medi-Cal appeal rights.
If requested by a plan, the director shall include this statement in a written report made available to the public and prepared by the director that describes or compares grievances that are pending and unresolved with the plan for 30 days or more. Additionally, the director shall, if requested by a plan, append to that written report a brief explanation, provided in writing by the plan, of the reasons why grievances described in that written report are pending and unresolved for 30 days or more. The director shall not be required to include a statement or append a brief explanation to a written report that the director is required to prepare under this chapter, including Sections 1380 and 1397.5.
(d)Subject to subparagraph (C) of paragraph (1) of subdivision (b), the grievance or resolution procedures authorized by this section shall be in addition to any other procedures that may be available to any person, and failure to pursue, exhaust, or engage in the procedures described in this section shall not preclude the use of any other remedy provided by law.
(e)Nothing in this section shall be construed to allow the submission to the department of any provider grievance under this section. However, as part of a providers duty to advocate for medically appropriate health care for his or her patients pursuant to Sections 510 and 2056 of the Business and Professions Code, nothing in this subdivision shall be construed to prohibit a provider from contacting and informing the department about any concerns he or she has regarding compliance with or enforcement of this chapter.
(f)To the extent required by Section 2719 of the federal Public Health Service Act (42 U.S.C. Sec. 300gg-19) and any subsequent rules or regulations, there shall be an independent external review pursuant to the standards required by the United States Secretary of Health and Human Services of a health care service plans cancellation, rescission, or nonrenewal of an enrollees or subscribers coverage.
SEC. 5.Section 1368.01 of the Health and Safety Code is amended to read:1368.01.(a) The grievance system shall require the plan to resolve grievances within 30 days, except as provided in subdivision (c). days.
(b) The grievance system shall include a requirement for expedited plan review of grievances for cases involving an imminent and serious threat to the health of the patient, including, but not limited to, severe pain, potential loss of life, limb, or major bodily function. When the plan has notice of a case requiring expedited review, the grievance system shall require the plan to immediately inform enrollees and subscribers in writing of their right to notify the department of the grievance. The grievance system shall also require the plan to provide enrollees, subscribers, and the department with a written statement on the disposition or pending status of the grievance no later than three days from receipt of the grievance, except as provided in subdivision (c). grievance. Paragraph (4) of subdivision (a) of Section 1368 shall not apply to grievances handled pursuant to this section.
(c)A health care service plan contract in the individual, small group, or large group markets that provides coverage for outpatient prescription drugs shall comply with subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations. This subdivision shall not apply to Medi-Cal managed care health care service plan contracts or any entity that enters into a contract with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000), Chapter 8 (commencing with Section 14200), or Chapter 8.75 (commencing with Section 14591) of Part 3 of Division 9 of the Welfare and Institutions Code.
SEC. 6.Section 1374.30 of the Health and Safety Code is amended to read:1374.30.(a)Commencing January 1, 2001, there is hereby established in the department the Independent Medical Review System.
(b)For the purposes of this chapter, disputed health care service means any health care service eligible for coverage and payment under a health care service plan contract that has been denied, modified, or delayed by a decision of the plan, or by one of its contracting providers, in whole or in part due to a finding that the service is not medically necessary. A decision regarding a disputed health care service relates to the practice of medicine and is not a coverage decision. A disputed health care service does not include services provided by a specialized health care service plan, except to the extent that the service (1) involves the practice of medicine, or (2) is provided pursuant to a contract with a health care service plan that covers hospital, medical, or surgical benefits. If a plan, or one of its contracting providers, issues a decision denying, modifying, or delaying health care services, based in whole or in part on a finding that the proposed health care services are not a covered benefit under the contract that applies to the enrollee, the statement of decision shall clearly specify the provision in the contract that excludes that coverage.
(c)For the purposes of this chapter, coverage decision means the approval or denial of health care services by a plan, or by one of its contracting entities, substantially based on a finding that the provision of a particular service is included or excluded as a covered benefit under the terms and conditions of the health care service plan contract. A coverage decision does not encompass a plan or contracting provider decision regarding a disputed health care service.
(d)(1)All enrollee grievances involving a disputed health care service are eligible for review under the Independent Medical Review System if the requirements of this article are met. If the department finds that an enrollee grievance involving a disputed health care service does not meet the requirements of this article for review under the Independent Medical Review System, the enrollee request for review shall be treated as a request for the department to review the grievance pursuant to subdivision (b) of Section 1368. All other enrollee grievances, including grievances involving coverage decisions, remain eligible for review by the department pursuant to subdivision (b) of Section 1368.
(2)In any case in which an enrollee or provider asserts that a decision to deny, modify, or delay health care services was based, in whole or in part, on consideration of medical necessity, the department shall have the final authority to determine whether the grievance is more properly resolved pursuant to an independent medical review as provided under this article or pursuant to subdivision (b) of Section 1368.
(3)The department shall be the final arbiter when there is a question as to whether an enrollee grievance is a disputed health care service or a coverage decision. The department shall establish a process to complete an initial screening of an enrollee grievance. If there appears to be any medical necessity issue, the grievance shall be resolved pursuant to an independent medical review as provided under this article or pursuant to subdivision (b) of Section 1368.
(e)Every health care service plan contract that is issued, amended, renewed, or delivered in this state on or after January 1, 2000, shall provide an enrollee with the opportunity to seek an independent medical review whenever health care services have been denied, modified, or delayed by the plan, or by one of its contracting providers, if the decision was based in whole or in part on a finding that the proposed health care services are not medically necessary. For purposes of this article, an enrollee may designate an agent to act on his or her behalf, as described in paragraph (2) of subdivision (b) of Section 1368. The provider may join with or otherwise assist the enrollee in seeking an independent medical review, and may advocate on behalf of the enrollee.
(f)Medi-Cal beneficiaries enrolled in a health care service plan shall not be excluded from participation. Medicare beneficiaries enrolled in a health care service plan shall not be excluded unless expressly preempted by federal law. Reviews of cases for Medi-Cal enrollees shall be conducted in accordance with statutes and regulations for the Medi-Cal program.
(g)The department may seek to integrate the quality of care and consumer protection provisions, including remedies, of the Independent Medical Review System with related dispute resolution procedures of other health care agency programs, including the Medicare and Medi-Cal programs, in a way that minimizes the potential for duplication, conflict, and added costs. Nothing in this subdivision shall be construed to limit any rights conferred upon enrollees under this chapter.
(h)The independent medical review process authorized by this article is in addition to any other procedures or remedies that may be available.
(i)Every health care service plan shall prominently display in every plan member handbook or relevant informational brochure, in every plan contract, on enrollee evidence of coverage forms, on copies of plan procedures for resolving grievances, on letters of denials issued by either the plan or its contracting organization, on the grievance forms required under Section 1368, and on all written responses to grievances, information concerning the right of an enrollee to request an independent medical review in cases where the enrollee believes that health care services have been improperly denied, modified, or delayed by the plan, or by one of its contracting providers.
(j)An enrollee may apply to the department for an independent medical review when all of the following conditions are met:
(1)(A)The enrollees provider has recommended a health care service as medically necessary, or
(B)The enrollee has received urgent care or emergency services that a provider determined was medically necessary, or
(C)The enrollee, in the absence of a provider recommendation under subparagraph (A) or the receipt of urgent care or emergency services by a provider under subparagraph (B), has been seen by an in-plan provider for the diagnosis or treatment of the medical condition for which the enrollee seeks independent review. The plan shall expedite access to an in-plan provider upon request of an enrollee. The in-plan provider need not recommend the disputed health care service as a condition for the enrollee to be eligible for an independent review.
For purposes of this article, the enrollees provider may be an out-of-plan provider. However, the plan shall have no liability for payment of services provided by an out-of-plan provider, except as provided pursuant to subdivision (c) of Section 1374.34.
(2)The disputed health care service has been denied, modified, or delayed by the plan, or by one of its contracting providers, based in whole or in part on a decision that the health care service is not medically necessary.
(3)(A)The enrollee has filed a grievance with the plan or its contracting provider pursuant to Section 1368, and the disputed decision is upheld or the grievance remains unresolved after 30 days. The enrollee shall not be required to participate in the plans grievance process for more than 30 days. In the case of a grievance that requires expedited review pursuant to Section 1368.01, the enrollee shall not be required to participate in the plans grievance process for more than three days. days, or
(B)The enrollee has filed for an external review decision with the plan or its contracting provider pursuant to subdivision (b) of Section 1367.24, and the disputed decision is upheld or the external review remains unresolved after 72 hours, or 24 hours if exigent circumstances exist.
(k)An enrollee may apply to the department for an independent medical review of a decision to deny, modify, or delay health care services, based in whole or in part on a finding that the disputed health care services are not medically necessary, within six months of any of the qualifying periods or events under subdivision (j). The director may extend the application deadline beyond six months if the circumstances of a case warrant the extension.
(l)The enrollee shall pay no application or processing fees of any kind.
(m)As part of its notification to the enrollee regarding a disposition of the enrollees grievance that denies, modifies, or delays health care services, the plan shall provide the enrollee with a one- or two-page application form approved by the department, and an addressed envelope, which the enrollee may return to initiate an independent medical review. The plan shall include on the form any information required by the department to facilitate the completion of the independent medical review, such as the enrollees diagnosis or condition, the nature of the disputed health care service sought by the enrollee, a means to identify the enrollees case, and any other material information. The form shall also include the following:
(1)Notice that a decision not to participate in the independent medical review process may cause the enrollee to forfeit any statutory right to pursue legal action against the plan regarding the disputed health care service.
(2)A statement indicating the enrollees consent to obtain any necessary medical records from the plan, any of its contracting providers, and any out-of-plan provider the enrollee may have consulted on the matter, to be signed by the enrollee.
(3)Notice of the enrollees right to provide information or documentation, either directly or through the enrollees provider, regarding any of the following:
(A)A provider recommendation indicating that the disputed health care service is medically necessary for the enrollees medical condition.
(B)Medical information or justification that a disputed health care service, on an urgent care or emergency basis, was medically necessary for the enrollees medical condition.
(C)Reasonable information supporting the enrollees position that the disputed health care service is or was medically necessary for the enrollees medical condition, including all information provided to the enrollee by the plan or any of its contracting providers, still in the possession of the enrollee, concerning a plan or provider decision regarding disputed health care services, and a copy of any materials the enrollee submitted to the plan, still in the possession of the enrollee, in support of the grievance, as well as any additional material that the enrollee believes is relevant.
(4)A section designed to collect information on the enrollees ethnicity, race, and primary language spoken that includes both of the following:
(A)A statement of intent indicating that the information is used for statistics only, in order to ensure that all enrollees get the best care possible.
(B)A statement indicating that providing this information is optional and will not affect the independent medical review process in any way.
(n)Upon notice from the department that the health care service plans enrollee has applied for an independent medical review, the plan or its contracting providers shall provide to the independent medical review organization designated by the department a copy of all of the following documents within three business days of the plans receipt of the departments notice of a request by an enrollee for an independent review:
(1)(A)A copy of all of the enrollees medical records in the possession of the plan or its contracting providers relevant to each of the following:
(i)The enrollees medical condition.
(ii)The health care services being provided by the plan and its contracting providers for the condition.
(iii)The disputed health care services requested by the enrollee for the condition.
(B)Any newly developed or discovered relevant medical records in the possession of the plan or its contracting providers after the initial documents are provided to the independent medical review organization shall be forwarded immediately to the independent medical review organization. The plan shall concurrently provide a copy of medical records required by this subparagraph to the enrollee or the enrollees provider, if authorized by the enrollee, unless the offer of medical records is declined or otherwise prohibited by law. The confidentiality of all medical record information shall be maintained pursuant to applicable state and federal laws.
(2)A copy of all information provided to the enrollee by the plan and any of its contracting providers concerning plan and provider decisions regarding the enrollees condition and care, and a copy of any materials the enrollee or the enrollees provider submitted to the plan and to the plans contracting providers in support of the enrollees request for disputed health care services. This documentation shall include the written response to the enrollees grievance, required by paragraph (4) of subdivision (a) of Section 1368. The confidentiality of any enrollee medical information shall be maintained pursuant to applicable state and federal laws.
(3)A copy of any other relevant documents or information used by the plan or its contracting providers in determining whether disputed health care services should have been provided, and any statements by the plan and its contracting providers explaining the reasons for the decision to deny, modify, or delay disputed health care services on the basis of medical necessity. The plan shall concurrently provide a copy of documents required by this paragraph, except for any information found by the director to be legally privileged information, to the enrollee and the enrollees provider. The department and the independent medical review organization shall maintain the confidentiality of any information found by the director to be the proprietary information of the plan.
(o)This section shall become operative on July 1, 2015.
SEC. 7.Section 10123.190 is added to the Insurance Code, immediately following Section 10123.19, to read:10123.190.(a)(1)Every health insurer that provides prescription drug benefits shall maintain an expeditious process, as described in this subdivision, by which insureds, insureds designees, or prescribing providers may request and obtain authorization for medically necessary nonformulary prescription drugs and medically necessary formulary drugs that require prior authorization by the health insurer. The health insurer shall provide that the insured, the insureds designee, or the insureds prescribing provider may seek a prior authorization for a prescription drug under this subdivision.
(2)Each health insurer shall respond to a prior authorization request within 72 hours following receipt of the prior authorization request. A health insurer that grants a prior authorization request under this paragraph shall provide coverage of the prescription drug for the duration of the prescription, including refills.
(3)Each health insurer shall provide that a prior authorization may be obtained within 24 hours if an insured is suffering from a health condition that may seriously jeopardize the insureds life, health, or ability to regain maximum function or if an insured is undergoing a current course of treatment using a nonformulary drug. A health insurer that grants a prior authorization request under this paragraph based on exigent circumstances shall provide coverage of the prescription drug for the duration of the exigency.
(4)If a health insurer fails to respond within 72 hours for a prior authorization request, or within 24 hours if exigent circumstances exist, upon receipt of a completed prior authorization request, the prior authorization request shall be deemed to have been granted.
(5)Each health insurer shall provide a written description of the process described in paragraph (1) to its prescribing providers. For purposes of this section, a prescribing provider shall include a provider authorized to write a prescription, pursuant to subdivision (a) of Section 4040 of the Business and Professions Code, to treat a medical condition of an insured.
(b)If a health insurer disapproves a prior authorization request made pursuant to subdivision (a), the health insurer shall maintain an expeditious process to authorize an insured to obtain an external review.
(1)A determination on an external review shall be made no later than 72 hours following receipt of the request, if the original request was an authorization request under paragraph (2) of subdivision (a), and no later than 24 hours following receipt of the request, if the original request was an authorization request under paragraph (3) of subdivision (a).
(2)If an external review decision of a prior authorization request under paragraph (2) of subdivision (a) is granted, the health insurer shall provide coverage of the prescription drug for the duration of the prescription, including refills. If an external review decision of a prior authorization request under paragraph (3) of subdivision (a) is granted, the health insurer shall provide coverage of the prescription drug for the duration of the exigency.
(c)Any health insurer that disapproves a request made pursuant to subdivision (a) to obtain authorization for a nonformulary or formulary drug shall provide the reasons for the disapproval in a notice provided to the insured. The notice shall indicate that the insured may file, in lieu of filing a grievance with the health insurer, a request for an external review pursuant to subdivision (b) if the insured objects to the disapproval, including any alternative drug or treatment offered by the health insurer. If a health insurer disapproves a request made pursuant to subdivision (a), an insured shall not be required to file a grievance with the health insurer or its contracting provider pursuant the grievance process established by the health insurer.
(d)The process described in subdivisions (a) and (b) by which insureds may obtain medically necessary nonformulary and formulary drugs shall be described in the evidence of coverage or certificate of insurance issued by the health insurer on or after July 1, 2017.
(e)A health insurance policy in the individual, small group, and large group markets that provides coverage for outpatient prescription drugs shall comply with this section.
(f)Nothing in this section shall be construed to affect an insureds or policyholders eligibility to submit a complaint to the department for review or to apply to the department for an independent medical review under Article 3.5 (commencing with Section 10169).
SEC. 8.Section 10123.191 of the Insurance Code is amended to read:10123.191.(a)Notwithstanding any other law, on and after January 1, 2013, a health insurer that provides coverage for prescription drugs shall utilize and accept only the prior authorization form developed pursuant to subdivision (c), (b), or an electronic prior authorization process described in subdivision (e), (d), when requiring prior authorization for prescription drugs.
(b)If a health insurer or a contracted physician group fails to respond within 72 hours for nonurgent requests, and within 24 hours if exigent circumstances exist, upon receipt of a completed prior authorization request from a prescribing provider, the prior authorization request shall be deemed to have been granted.
(c)
(b)On or before January 1, 2017, the department and the Department of Managed Health Care shall jointly develop a uniform prior authorization form. Notwithstanding any other law, on and after July 1, 2017, or six months after the form is completed pursuant to this section, whichever is later, every prescribing provider shall use that uniform prior authorization form, or an electronic prior authorization process described in subdivision (e), (d), to request prior authorization for coverage of prescription drugs and every health insurer shall accept that form or electronic process as sufficient to request prior authorization for prescription drugs.
(d)
(c)The prior authorization form developed pursuant to subdivision (c) (b) shall meet the following criteria:
(1)The form shall not exceed two pages.
(2)The form shall be made electronically available by the department and the health insurer.
(3)The completed form may also be electronically submitted from the prescribing provider to the health insurer.
(4)The department and the Department of Managed Health Care shall develop the form with input from interested parties from at least one public meeting.
(5)The department and the Department of Managed Health Care, in development of the standardized form, shall take into consideration the following:
(A)Existing prior authorization forms established by the federal Centers for Medicare and Medicaid Services and the State Department of Health Care Services.
(B)National standards pertaining to electronic prior authorization.
(e)
(d)A prescribing provider may use an electronic prior authorization system utilizing the standardized form described in subdivision (c) (b) or an electronic process developed specifically for transmitting prior authorization information that meets the National Council for Prescription Drug Programs SCRIPT standard for electronic prior authorization transactions.
(f)
(e)Subdivision (a) does not apply if any of the following occurs:
(1)A contracted physician group is delegated the financial risk for the pharmacy or medical drug benefit by a health insurer.
(2)A contracted physician group uses its own internal prior authorization process rather than the health insurers prior authorization process for the health insurers insureds.
(3)A contracted physician group is delegated a utilization management function by the health insurer concerning any prescription drug, regardless of the delegation of financial risk.
(g)
(f)For prescription drugs, prior authorization requirements described in subdivisions (c) (b) and (e) (d) apply regardless of how that benefit is classified under the terms of the health insurers group or individual policy.
(h)A health insurer shall maintain a process for an external exception request review that complies with subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations.
(i)For an individual, small group, or large group health insurance policy, a health insurer that provides coverage for outpatient prescription drugs shall comply with subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations.
(j)
(g)For purposes of this section:
(1)Prescribing provider shall include a provider authorized to write a prescription, pursuant to subdivision (a) of Section 4040 of the Business and Professions Code, to treat a medical condition of an insured.
(2)Exigent circumstances exist when an insured is suffering from a health condition that may seriously jeopardize the insureds life, health, or ability to regain maximum function or when an insured is undergoing a current course of treatment using a nonformulary drug.
(3)
(2)Completed prior authorization request means a completed uniform prior authorization form developed pursuant to subdivision (c), (b), or a completed request submitted using an electronic prior authorization system described in subdivision (e), (d), or, for contracted physician groups described in subdivision (f), (e), the process used by the contracted physician group.
SEC. 9.Section 10123.197 of the Insurance Code is amended to read:10123.197.(a)A request for an exception to a health insurers step therapy process for prescription drugs may be submitted in the same manner as a request for prior authorization for prescription drugs pursuant to Section 10123.191, 10123.190 and shall be treated in the same manner, and shall be responded to by the health insurer in the same manner, as a request for prior authorization for prescription drugs.
(b)The department and the Department of Managed Health Care shall include a provision for step therapy exception requests in the uniform prior authorization form developed pursuant to subdivision (c) (b) of Section 10123.191.
SEC. 10.Section 10169 of the Insurance Code, as added by Section 19 of Chapter 348 of the Statutes of 2015, is amended to read:10169.(a)Commencing January 1, 2001, there is hereby established in the department the Independent Medical Review System.
(b)For the purposes of this chapter, disputed health care service means any health care service eligible for coverage and payment under a disability insurance contract that has been denied, modified, or delayed by a decision of the insurer, or by one of its contracting providers, in whole or in part due to a finding that the service is not medically necessary. A decision regarding a disputed health care service relates to the practice of medicine and is not a coverage decision. A disputed health care service does not include services provided by a group or individual policy of vision-only or dental-only coverage, except to the extent that (1) the service involves the practice of medicine, or (2) is provided pursuant to a contract with a disability insurer that covers hospital, medical, or surgical benefits. If an insurer, or one of its contracting providers, issues a decision denying, modifying, or delaying health care services, based in whole or in part on a finding that the proposed health care services are not a covered benefit under the contract that applies to the insured, the statement of decision shall clearly specify the provision in the contract that excludes that coverage.
(c)For the purposes of this chapter, coverage decision means the approval or denial of health care services by a disability insurer, or by one of its contracting entities, substantially based on a finding that the provision of a particular service is included or excluded as a covered benefit under the terms and conditions of the disability insurance contract. A coverage decision does not encompass a disability insurer or contracting provider decision regarding a disputed health care service.
(d)(1)All insured grievances involving a disputed health care service are eligible for review under the Independent Medical Review System if the requirements of this article are met. If the department finds that an insured grievance involving a disputed health care service does not meet the requirements of this article for review under the Independent Medical Review System, the insured request for review shall be treated as a request for the department to review the grievance. All other insured grievances, including grievances involving coverage decisions, remain eligible for review by the department.
(2)In any case in which an insured or provider asserts that a decision to deny, modify, or delay health care services was based, in whole or in part, on consideration of medical necessity, the department shall have the final authority to determine whether the grievance is more properly resolved pursuant to an independent medical review as provided under this article.
(3)The department shall be the final arbiter when there is a question as to whether an insured grievance is a disputed health care service or a coverage decision. The department shall establish a process to complete an initial screening of an insured grievance. If there appears to be any medical necessity issue, the grievance shall be resolved pursuant to an independent medical review as provided under this article.
(e)Every disability insurance contract that is issued, amended, renewed, or delivered in this state on or after January 1, 2000, shall provide an insured with the opportunity to seek an independent medical review whenever health care services have been denied, modified, or delayed by the insurer, or by one of its contracting providers, if the decision was based in whole or in part on a finding that the proposed health care services are not medically necessary. For purposes of this article, an insured may designate an agent to act on his or her behalf. The provider may join with or otherwise assist the insured in seeking an independent medical review, and may advocate on behalf of the insured.
(f)Medicare beneficiaries enrolled in Medicare + Choice products shall not be excluded unless expressly preempted by federal law.
(g)The department may seek to integrate the quality of care and consumer protection provisions, including remedies, of the Independent Medical Review System with related dispute resolution procedures of other health care agency programs, including the Medicare program, in a way that minimizes the potential for duplication, conflict, and added costs. Nothing in this subdivision shall be construed to limit any rights conferred upon insureds under this chapter.
(h)The independent medical review process authorized by this article is in addition to any other procedures or remedies that may be available.
(i)Every disability insurer shall prominently display in every insurer member handbook or relevant informational brochure, in every insurance contract, on insured evidence of coverage forms, on copies of insurer procedures for resolving grievances, on letters of denials issued by either the insurer or its contracting organization, and on all written responses to grievances, information concerning the right of an insured to request an independent medical review when the insured believes that health care services have been improperly denied, modified, or delayed by the insurer, or by one of its contracting providers. The departments telephone number, 1-800-927-4357, and Internet Web site, www.insurance.ca.gov, shall also be displayed.
(j)An insured may apply to the department for an independent medical review when all of the following conditions are met:
(1)(A)The insureds provider has recommended a health care service as medically necessary, or
(B)The insured has received urgent care or emergency services that a provider determined was medically necessary, or
(C)The insured, in the absence of a provider recommendation under subparagraph (A) or the receipt of urgent care or emergency services by a provider under subparagraph (B), has been seen by a contracting provider for the diagnosis or treatment of the medical condition for which the insured seeks independent review. The insurer shall expedite access to a contracting provider upon request of an insured. The contracting provider need not recommend the disputed health care service as a condition for the insured to be eligible for an independent review.
For purposes of this article, the insureds provider may be a noncontracting provider. However, the insurer shall have no liability for payment of services provided by a noncontracting provider, except as provided pursuant to Section 10169.3.
(2)The disputed health care service has been denied, modified, or delayed by the insurer, or by one of its contracting providers, based in whole or in part on a decision that the health care service is not medically necessary.
(3)(A)The insured has filed a grievance with the insurer or its contracting provider, and the disputed decision is upheld or the grievance remains unresolved after 30 days. The insured shall not be required to participate in the insurers grievance process for more than 30 days. In the case of a grievance that requires expedited review, the insured shall not be required to participate in the insurers grievance process for more than three days. days, or
(B)The insured has filed for an external review decision with the insurer or its contracting provider pursuant to subdivision (b) of Section 10123.190, and the disputed decision is upheld or the external review remains unresolved after 72 hours, or 24 hours if exigent circumstances exist.
(k)An insured may apply to the department for an independent medical review of a decision to deny, modify, or delay health care services, based in whole or in part on a finding that the disputed health care services are not medically necessary, within six months of any of the qualifying periods or events under subdivision (j). The commissioner may extend the application deadline beyond six months if the circumstances of a case warrant the extension.
(l)The insured shall pay no application or processing fees of any kind.
(m)As part of its notification to the insured regarding a disposition of the insureds grievance that denies, modifies, or delays health care services, the insurer shall provide the insured with a one- or two-page application form approved by the department, and an addressed envelope, which the insured may return to initiate an independent medical review. The insurer shall include on the form any information required by the department to facilitate the completion of the independent medical review, such as the insureds diagnosis or condition, the nature of the disputed health care service sought by the insured, a means to identify the insureds case, and any other material information. The form shall also include the following:
(1)Notice that a decision not to participate in the independent review process may cause the insured to forfeit any statutory right to pursue legal action against the insurer regarding the disputed health care service.
(2)A statement indicating the insureds consent to obtain any necessary medical records from the insurer, any of its contracting providers, and any noncontracting provider the insured may have consulted on the matter, to be signed by the insured.
(3)Notice of the insureds right to provide information or documentation, either directly or through the insureds provider, regarding any of the following:
(A)A provider recommendation indicating that the disputed health care service is medically necessary for the insureds medical condition.
(B)Medical information or justification that a disputed health care service, on an urgent care or emergency basis, was medically necessary for the insureds medical condition.
(C)Reasonable information supporting the insureds position that the disputed health care service is or was medically necessary for the insureds medical condition, including all information provided to the insured by the insurer or any of its contracting providers, still in the possession of the insured, concerning an insurer or provider decision regarding disputed health care services, and a copy of any materials the insured submitted to the insurer, still in the possession of the insured, in support of the grievance, as well as any additional material that the insured believes is relevant.
(4)A section designed to collect information on the insureds ethnicity, race, and primary language spoken that includes both of the following:
(A)A statement of intent indicating that the information is used for statistics only, in order to ensure that all insureds get the best care possible.
(B)A statement indicating that providing this information is optional and will not affect the independent medical review process in any way.
(n)Upon notice from the department that the insured has applied for an independent medical review, the insurer or its contracting providers, shall provide to the independent medical review organization designated by the department a copy of all of the following documents within three business days of the insurers receipt of the departments notice of a request by an insured for an independent review:
(1)(A)A copy of all of the insureds medical records in the possession of the insurer or its contracting providers relevant to each of the following:
(i)The insureds medical condition.
(ii)The health care services being provided by the insurer and its contracting providers for the condition.
(iii)The disputed health care services requested by the insured for the condition.
(B)Any newly developed or discovered relevant medical records in the possession of the insurer or its contracting providers after the initial documents are provided to the independent medical review organization shall be forwarded immediately to the independent medical review organization. The insurer shall concurrently provide a copy of medical records required by this subparagraph to the insured or the insureds provider, if authorized by the insured, unless the offer of medical records is declined or otherwise prohibited by law. The confidentiality of all medical record information shall be maintained pursuant to applicable state and federal laws.
(2)A copy of all information provided to the insured by the insurer and any of its contracting providers concerning insurer and provider decisions regarding the insureds condition and care, and a copy of any materials the insured or the insureds provider submitted to the insurer and to the insurers contracting providers in support of the insureds request for disputed health care services. This documentation shall include the written response to the insureds grievance. The confidentiality of any insured medical information shall be maintained pursuant to applicable state and federal laws.
(3)A copy of any other relevant documents or information used by the insurer or its contracting providers in determining whether disputed health care services should have been provided, and any statements by the insurer and its contracting providers explaining the reasons for the decision to deny, modify, or delay disputed health care services on the basis of medical necessity. The insurer shall concurrently provide a copy of documents required by this paragraph, except for any information found by the commissioner to be legally privileged information, to the insured and the insureds provider. The department and the independent medical review organization shall maintain the confidentiality of any information found by the commissioner to be the proprietary information of the insurer.
(o)This section shall become operative on January 1, 2017.
SEC. 11.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
|
Date
|
Status
|
|---|---|
| May 27, 2016 | In committee: Held under submission. |
| May 4, 2016 | In committee: Set, first hearing. Referred to APPR. suspense file. |
| Apr 7, 2016 | Re-referred to Com. on APPR. |
| Apr 6, 2016 | Read second time and amended. |
| Apr 5, 2016 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 13. Noes 2.) (March 29). |
| Mar 28, 2016 | Re-referred to Com. on HEALTH. |
| Mar 17, 2016 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. |
| Mar 8, 2016 | Referred to Com. on HEALTH. |
| Feb 19, 2016 | From printer. May be heard in committee March 20. |
| Feb 18, 2016 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Mar 29, 2016 | Do pass as amended and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Health |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Date of Hearing: May 4, 2016
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Lorena Gonzalez, Chair
ABPCA Bill Id:AB 2400
Author:(Nazarian) – As Amended Ver:April 6, 2016
Policy Committee: | Health | Vote: | 13 - 2 |
|
| ||
|
|
Urgency: No State Mandated Local Program: Yes Reimbursable: No
SUMMARY:
This bill requires health care service plans (health plans) and health insurers to comply with a shortened internal appeals process for coverage decisions on formulary drugs.
FISCAL EFFECT:
- Costs to the Department of Managed Health Care (DMHC) for legal, licensing, and plan surveys, as well as enforcement in the range of $200,000 in 2016-17, $550,000 in 2017-18, and approximately $500,000 in 2018-19 and ongoing (Managed Care Fund). The bulk of the costs are for an increase in referrals to enforcement.
- Costs of $35,000 over two years, and $5,000 ongoing of the California Department of Insurance to verify and ensure compliance (Insurance Fund).
- One-time costs to the Department of Health Care Services of $110,000 to provide guidance and update contracts, and ongoing costs of $100,000 to monitor compliance of managed care plans with the new requirements (GF/federal).
- Health plans believe this bill will significantly increase administrative resources and staff costs to provide more rapid responses. Additionally, if there were more denials due to insufficient time, plans expect more independent medical reviews of the denials. Increased health plan administrative costs can be passed on to consumers, employers, and government payers through higher premiums. However, the extent of potential increased health plan administrative costs is unknown. If the volume of formulary versus non-formulary appeals was known, the implementation costs plans are experiencing to comply with new federal rules requiring a 24/72 hour time frame for non-formulary drugs would serve as a useful guidepost for estimating plan administrative costs for applying the same time frame to formulary drugs.
COMMENTS:
- Purpose. The author states that this bill ensures consistency in the appeal process for all prescription drugs, whether the drugs are on the formulary or not, specifically with respect to the timeframe for appeal.
- Formulary versus non-formulary drugs. Pursuant to federal law, most plans must cover essential health benefits, including pharmacy benefits. Current federal rules establish minimum requirements for formularies, or a list of drugs that are covered by the plan, to ensure it is comprehensive. However, even with a comprehensive formulary, an individual may need to request a drug that is not on the formulary. Beginning this year, a federal rule requires plans to have a “standard exceptions process,” whereby an enrollee or physician can request coverage of a clinically appropriate non-formulary drug. The rule specifies a coverage decision must be rendered by the plan in non-exigent circumstances within 72 hours of a request, and within 24 hours for exigent circumstances, as defined. The purpose of the federal regulations was to ensure plans have a process was in place to allow coverage of medically necessary drugs that are otherwise not covered by the plan. Federal regulators at the Centers for Medicare and Medicaid Services (CMS) considered applying the same timeline to requests for drugs that are on a plan's formulary, but declined to do so. This bill would do so in state law.
Absent this bill, requests for coverage of formulary drugs that may have prior authorization requirements, as well as requests for all other health care products and services, are governed by existing statutory timelines. Current law requires coverage decisions within 30 days for routine requests, and within 72 hours for urgent (expedited) requests.
- Support. This bill is supported by the Arthritis Foundation and the California Life Sciences Association, who cite a higher level of service to the patient and equity between formulary and non-formulary drugs. They also cite anecdotal evidence related to persons requesting arthritis drugs, and explain that though it is difficult to prove that issues are urgent in order to provide an expedited review, issues may become clinically urgent when there are significant delays in receiving drugs.
- Opposition. Health plans and insurers, the California Chamber of Commerce, and health insurance agents oppose this bill, citing increased costs and administrative burden of more rapid reviews, as well as potential increases in unnecessary health spending. According to plans, this bill could potentially lead to a higher number of either approvals that would otherwise be denied upon careful review, which could increase unnecessary drug spending, or denials that would either be uncontested (meaning the consumer would not receive coverage for the drug) or require an entirely new appeal, namely independent medical review, in order to receive coverage.
- Staff Comments. Current state law requirements were put in place to align with federal regulatory requirements related to non-formulary drugs. This bill aligns timelines for formulary drugs with that of non-formulary drugs, but maintains an inequity in state law between drugs and all other health care products and services. Putting much shorter time frames into law changes the economics of health plan reviews by increasing their cost, potentially reducing a plans' and insurers' incentive or ability to provide a thorough review of appropriateness and cost-effectiveness. Although shortening time frames appears consumer-friendly, plans raise some noteworthy concerns about potential unintended consequences that may increase costs without a commensurate benefit to consumers, as noted above. More rapid timelines also will increase the likelihood of health plans not meeting the timelines, leading to more enforcement actions and increasing state costs. Although it is clear that up to 30 days for a coverage decision as allowed under current law is longer than most consumers would want to wait, it is unclear whether the proposed timeline appropriately balances state costs and health plan administrative costs with an overall benefit to consumers. Finally, the number of requests for formulary drugs subject to the shorter timelines in this bill is unknown, as well as the current average review time, making it difficult to know how large the potential impact is, nor how significantly this would shorten the average time to review.
Analysis Prepared by: Lisa Murawski / APPR. / (916) 319-2081
Date of Hearing: March 29, 2016
ASSEMBLY COMMITTEE ON HEALTH
Jim Wood, Chair
ABPCA Bill Id:AB 2400 (
Author:Nazarian) – As Amended Ver:March 17, 2016
SUBJECT: Prescription drug coverage: prior authorization and external review.
SUMMARY: Requires health care service plans (health plans) and health insurers to comply with a shortened internal grievance review process for formulary drugs. Specifically, this bill:
- Requires a health plan or health insurer to resolve grievances within 72 hours for non-urgent request and within 24 hours if exigent circumstances exist, if the health plan or health insurer disapproves a request for prior authorization of a formulary drug.
- Provides that an enrollee is not required to file a 30 day grievance with the health plan if a health plan disapproves a request for prior authorization of a non-formulary drug. Requires the health plan to treat the enrollee’s appeal as a request to obtain an external request review.
- Clarifies existing law to provide for the external exception request for non-formulary drugs in the Department of Managed Health Care’s (DMHC) grievance and appeal process.
- Requires an external exception review process for non-formulary drugs and grievance process for formulary drugs before an appeal can be brought to the DMHC’s or Department of Insurance’s (CDI) Independent Medical Review (IMR).
- Makes other technical and conforming changes.
EXISTING LAW:
- Regulates health plans under the Knox-Keene Health Care Service Plan Act of 1975 through the DMHC and regulates health insurers under the Insurance Code through the CDI.
- Mandates the 10 federally required essential health benefits (EHBs) in the individual and small group market and establishes the Kaiser Small Group health plan as California’s EHB benchmark plan, including prescription drug benefits, as specified, and incorporates by reference state law and regulations related to outpatient prescription drug coverage.
- Requires health plans that provide prescription drug benefits to provide coverage for all medically necessary outpatient drugs, except as specified.
- Requires health plans to maintain an expeditious process by which prescribing providers may obtain authorization for a medically necessary non-formulary prescription drug.
- Requires health plans and health insurers that provide prescription drug benefits and maintain drug formularies to post the formulary or formularies for each product offered by the health plan or health insurer on the health plan's or insurer’s website in a manner that is accessible and searchable by potential enrollees and insureds, enrollees, insureds and providers.
- Requires DMHC and CDI to develop a standard formulary template that contains specified information by January 1, 2017. Requires health plans and health insurers to use the standard formulary template within six months of the date the template is developed by DMHC and CDI.
- Requires health plans and health insurers to update their posted formularies with any change to those formularies on a monthly basis.
- Requires health plans to maintain the following:
- Complete drug formulary or formularies, including a list of prescription drugs on the formulary of the plan by major therapeutic category with an indication of whether any drugs are preferred over other drugs;
- Records developed by the pharmacy and therapeutic committee of the health plan that fully describe the reasoning behind formulary decisions; and,
- Health plan arrangements with entities that are associated with activities of the health plan to encourage formulary compliance or otherwise manage prescription drug benefits.
- Requires DMHC and CDI to jointly develop a uniform prior authorization form that health plans and health insurers must accept when prescribing providers seek authorization for prescription drug benefits. Requires prescribers to use the standardized prior authorization form. Provides that if a health plan or health insurer fails to utilize or accept the prior authorization form, or fails to respond within 72 hours for non-urgent requests and within 24 hours when exigent circumstances exist, the prior authorization request is deemed granted.
- Requires health plans and health insurers offering outpatient prescription drugs in the individual, small group, or large group markets to comply with the request for exception appeal process for non-formulary drugs as described in the Federal Regulations.
- Establishes the IMR process as part of the DMHC or CDI appeal process. Makes IMR available to the enrollee or insured after participation in a health plan or health insurer’s grievance process.
FISCAL EFFECT: This bill has not yet been analyzed by a fiscal committee.
COMMENTS:
- PURPOSE OF THIS BILL. According to the author, federal law leaves consumers at a disadvantage because consumers that select a particular plan because their medication is on the formulary face a longer appeal process compared to a plan that did not have their medication on the formulary. The author states that this bill ensures consistency in the appeal process for all prescription drugs, whether the drugs are on the formulary or not, specifically with respect to the timeframe for appeal. The author contends that delays in access to drugs can exacerbate a patient’s condition and cause irreversible deterioration or damage to patients, which can limit their daily functions and ability to remain a productive member of the workforce and society.
- BACKGROUND.
- Federal Law and Regulations. Federal regulations provide for a request for exception process for non-formulary drugs as follows:
- Request for exception. A health plan providing EHBs must have a process in place to allow an enrollee, the enrollee’s designee, or the enrollee’s prescribing physician to request and gain access to clinically appropriate drugs not covered by the health plan, i.e., non-formulary drugs;
- Standard exception request. A health plan must have a process for an enrollee to request a standard review of a decision that a drug is not covered by the health plan. A health plan must make its determination on a standard exception no later than 72 hours following receipt of the request. A health plan or health insurer will also have a process for expedited review, no less than 24 hours, based on exigent circumstances. Exigent circumstances exist when an enrollee is suffering from a health condition that may seriously jeopardize the enrollee’s life, health, or ability to regain maximum function or when an enrollee is undergoing a current course of treatment using non-formulary drugs; and,
- External exception request review. A health plan must also make available an external exception request process when a plan denies coverage during its standard review process. The original standard request and subsequent denial must be reviewed by an independent medical organization. A health plan must make a determination no later than 72 hours or 24 hours if exigent circumstances exist.
- Request for exception. A health plan providing EHBs must have a process in place to allow an enrollee, the enrollee’s designee, or the enrollee’s prescribing physician to request and gain access to clinically appropriate drugs not covered by the health plan, i.e., non-formulary drugs;
- Non-formulary drugs. The enactment of SB 282 (Hernandez), Chapter 654, Statutes of 2015, adopted federal regulations for requesting for an exception process for non-formulary drugs (subdivision (c) of Section 156.122 of Title 45 of the Code of Federal Regulations), as summarized above, but applicable to only non-formulary drugs.
- Grievance and Appeal process. Generally, a health plan or health insurer must make a determination regarding a denial of health care services within 30 days (if expedited, then 72 hours or less). An enrollee or insured may file a complaint with the DMHC or CDI to appeal a denial. Generally, if the denial is based upon medical necessity, then the complaint may be eligible for an IMR in which independent medical professionals will review the medical decision made by a health plan or health insurer. Absent expedited review, IMR review and determination can take up to 30 days.
- Federal Law and Regulations. Federal regulations provide for a request for exception process for non-formulary drugs as follows:
- SUPPORT. The Arthritis Foundation, the sponsor of this bill, states that this bill will align the grievance timelines for formulary drugs with what is already required for non-formulary drugs. The sponsor also states that this bill clarifies that an enrollee seeking access to a non-formulary drug is not required to exhaust the health plan’s internal grievance process before request their external exception process. The sponsor contends that this bill ensures consistency in the grievance process for all prescription drugs, regardless of the formulary design. The sponsor asserts that lengthy delays in appealing a health plan’s denial through their internal grievance process, which can take up to 30 days, can lead to irreversible damage and joint destruction as well as increased utilization of health care services. Other supporters note that federal guidance has created additional review processes and quicker timeframes for non-formulary drugs, and therefore support the application of 72 or 24 hours to formulary drugs as well as non-formulary drugs.
- OPPOSITION. The Association of California Life & Health Insurance Companies (ACLHIC) states that this bill would diminish an insurer’s ability to effectively and thoughtfully review formulary drug exception requests since it can take several days to collect all the information necessary to complete a request. Furthermore, ACLHIC argues that it is unclear why prescription drug exception requests should be given preferential treatment over all other medical service reviews. ACLHIC raises concerns regarding prescription drug abuse and this bill limiting the plans’ ability to thoroughly review whether or not it is appropriate to prescribe a particular drug. ACLHIC contends that it is critical that health insurers continue to be diligent in their efforts to ensure that providers are adhering to evidence-based practices and delivering quality healthcare to their members. The California Chamber of Commerce (Chamber) also opposes this bill because it will drive up health care premiums without providing a substantial benefit for enrollees. The Chamber notes that the federal Department of Health and Human Services indicated that its decision not to apply the shortened timeline to formulary drugs was one reason it did not believe that the new requirements for non-formulary drugs would significantly increase the administrative cost burden on health care issuers, and therefore suggesting that shortening the timeline for all prescription drugs, as proposed in this bill, is unnecessary and likely to increase administrative costs for plans. The Chamber argues that health care costs can increase if health plans hire more staff and/or if staff makes more cursory decision about each request received. Finally, the Chamber notes that many prior authorization requirements related to formulary drugs are designed to protect enrollees, for example, opioid pain killers and drugs with potentially dangerous side effects. The Chamber contends that if health plans or health insurers are rushed to approve these requests, it could undermine quality of care.
The California Association of Health Plans (CAHP) and Blue Shield of California raises concerns on the existing appeal process indicating that the IMR process should be reserved for more significant disagreements over the medical necessity of a covered service and contends that this bill could clog the process with prescription drug cases that could have been resolved internally at the plan level if the appropriate review time is given. CAHP also notes that health plans and regulators are currently interpreting how the new external review process fits into existing exception processes and a new law may complicate efforts to determine whether efficient processes are still available.
- RECENT LEGISLATION.
- SB 866 (Hernandez), Chapter 648, Statutes of 2011, requires DMHC and CDI to jointly develop a uniform prior authorization form that health plans and insurers must accept when prescribing providers seek authorization for prescription drug benefits.
- SB 282 (Hernandez), Chapter 654, Statutes of 2015, authorizes a prescribing provider to use an electronic prior authorization system that utilizes the standardized form or an electronic process developed specifically for transmuting prior authorization information that is consistent with the standardized form and that meets the National Council for Prescription Drug Programs’ SCRIPT standard for electronic prior authorization transactions. SB 282 also deemed a prior authorization request granted if the health plan or insurer filed to respond within 72 hours for a nonurgent request and within 24 hours for exigent circumstances.
- POLICY COMMENTS. This bill addresses the internal appeal process at the health plan or health insurer level by identifying a 72 or 24 hour appeal timeframe for review, however, does not address the external exception request review process (i.e., denial reviewed by an independent review organization) for formulary drugs. While an external exception request process may be costly, as this bill moves forward, the author may wish to explore adding this requirement.
- TECHNICAL AMENDMENT. Legislative Counsel inadvertently deleted the “or” in Health and Safety Code Section 1374.30(j) but this language must be included so as to not change existing law requirements, as follows:
(j) An enrollee may apply to the department for an independent medical review when all of the following conditions are met:
(1) (A) The enrollee’s provider has recommended a health care service as medically necessary, or necessary, or
(B) The enrollee has received urgent care or emergency services that a provider determined was medically necessary, or necessary, or
(C) The enrollee, in the absence of a provider recommendation under subparagraph (A) or the receipt of urgent care or emergency services by a provider under subparagraph (B), has been seen by an in-plan provider for the diagnosis or treatment of the medical condition for which the enrollee seeks independent review. The plan shall expedite access to an in-plan provider upon request of an enrollee. The in-plan provider need not recommend the disputed health care service as a condition for the enrollee to be eligible for an independent review.
REGISTERED SUPPORT / OPPOSITION:
Support
Arthritis Foundation (sponsor)
California Life Sciences Association
Western Center on Law and Poverty
Opposition
Association of California Life & Health Insurance Companies
Blue Shield of California
California Association of Health Plans
California Chamber of Commerce
Analysis Prepared by: Kristene Mapile / HEALTH / (916) 319-2097
Discussed in Hearing
Senate Standing Committee on Appropriations
Assembly Standing Committee on Health
Bill Author
Bill Co-Author(s):